<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK201978" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK201978/" /><meta name="ncbi_pagename" content="KCNQ3-Related Disorders - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>KCNQ3-Related Disorders - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="KCNQ3-Related Disorders" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/09/07" /><meta name="citation_author" content="Francesco Miceli" /><meta name="citation_author" content="Maria Virginia Soldovieri" /><meta name="citation_author" content="Nishtha Joshi" /><meta name="citation_author" content="Sarah Weckhuysen" /><meta name="citation_author" content="Edward C Cooper" /><meta name="citation_author" content="Maurizio Taglialatela" /><meta name="citation_pmid" content="24851285" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK201978/" /><meta name="citation_keywords" content="Benign Familial Neonatal Epilepsy (BFNE)" /><meta name="citation_keywords" content="Benign Familial Infantile Epilepsy (BFIE)" /><meta name="citation_keywords" content="KCNQ3-Related Developmental Disability" /><meta name="citation_keywords" content="Potassium voltage-gated channel subfamily KQT member 3" /><meta name="citation_keywords" content="KCNQ3" /><meta name="citation_keywords" content="KCNQ3-Related Disorders" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="KCNQ3-Related Disorders" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Francesco Miceli" /><meta name="DC.Contributor" content="Maria Virginia Soldovieri" /><meta name="DC.Contributor" content="Nishtha Joshi" /><meta name="DC.Contributor" content="Sarah Weckhuysen" /><meta name="DC.Contributor" content="Edward C Cooper" /><meta name="DC.Contributor" content="Maurizio Taglialatela" /><meta name="DC.Date" content="2017/09/07" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK201978/" /><meta name="description" content="KCNQ3-related disorders include benign familial neonatal epilepsy (BFNE) and benign familial infantile epilepsy (BFIE), seizure disorders that occur in children who typically have normal psychomotor development. An additional KCNQ3-related disorder involves developmental disability." /><meta name="og:title" content="KCNQ3-Related Disorders" /><meta name="og:type" content="book" /><meta name="og:description" content="KCNQ3-related disorders include benign familial neonatal epilepsy (BFNE) and benign familial infantile epilepsy (BFIE), seizure disorders that occur in children who typically have normal psychomotor development. An additional KCNQ3-related disorder involves developmental disability." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK201978/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/kcnq3-dis/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK201978/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE88FE4DE040EED100000000019D0084.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK201978_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK201978_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/bfns/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/kcnt1-epilepsy/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK201978_"><span class="title" itemprop="name"><i>KCNQ3</i>-Related Disorders</span></h1><p class="contrib-group"><span itemprop="author">Francesco Miceli</span>, PhD, <span itemprop="author">Maria Virginia Soldovieri</span>, PhD, <span itemprop="author">Nishtha Joshi</span>, BDS, MPH, <span itemprop="author">Sarah Weckhuysen</span>, MD, PhD, <span itemprop="author">Edward C Cooper</span>, MD, PhD, and <span itemprop="author">Maurizio Taglialatela</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK201978_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK201978_ai__"><div class="contrib half_rhythm"><span itemprop="author">Francesco Miceli</span>, PhD<div class="affiliation small">Division of Pharmacology<br />Department of Neuroscience<br />University of Naples Federico II<br />Naples, Italy<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.aninu@ilecimrf" class="oemail">ti.aninu@ilecimrf</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Maria Virginia Soldovieri</span>, PhD<div class="affiliation small">Department of Health Science<br />University of Molise<br />Campobasso, Italy<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.lominu@ireivodlos.ainigrivairam" class="oemail">ti.lominu@ireivodlos.ainigrivairam</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Nishtha Joshi</span>, BDS, MPH<div class="affiliation small">Department of Neurology<br />Baylor College of Medicine<br />Houston, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamg@31ahthsin.ihsoj" class="oemail">moc.liamg@31ahthsin.ihsoj</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Sarah Weckhuysen</span>, MD, PhD<div class="affiliation small">Neurogenetics Group, VIB Center of Molecular Genetics<br />University of Antwerp</div><div class="affiliation small">Neurology Department<br />University Hospital<br />Antwerp, Belgium<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="eb.neprewtnau@nesyuhkcew.haras" class="oemail">eb.neprewtnau@nesyuhkcew.haras</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Edward C Cooper</span>, MD, PhD<div class="affiliation small">Departments of Neurology, Neuroscience, and Molecular and Human Genetics<br />Baylor College of Medicine<br />Houston, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.mcb@1cce" class="oemail">ude.mcb@1cce</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Maurizio Taglialatela</span>, MD, PhD<div class="affiliation small">Division of Pharmacology<br />Department of Neuroscience<br />University of Naples Federico II<br />Naples, Italy<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.lominu@aletalailgat.m" class="oemail">ti.lominu@aletalailgat.m</a><span style="unicode-bidi: bidi-override; direction: ltr;">; </span><a href="mailto:dev@null" data-email="ti.aninu@lailgatm" class="oemail">ti.aninu@lailgatm</a><div></div></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">May 22, 2014</span>; Last Update: <span itemprop="dateModified">September 7, 2017</span>.</p><p><em>Estimated reading time: 31 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="kcnq3-dis.Summary" itemprop="description"><h2 id="_kcnq3-dis_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>KCNQ3</i>-related disorders include benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> neonatal epilepsy (BFNE) and benign familial infantile epilepsy (BFIE), seizure disorders that occur in children who typically have normal psychomotor development. An additional <i>KCNQ3</i>-related disorder involves developmental disability.</p><ul><li class="half_rhythm"><div>In BFNE seizures begin in an otherwise healthy infant between days two and eight of life and spontaneously disappear between the first and the sixth to 12th month of life. Seizures are generally brief, lasting one to two minutes. Seizure types include tonic or apneic episodes, focal clonic activity, and autonomic changes. Motor activity may be confined to one body part, migrate to other regions, or generalize. Infants are well between seizures and feed normally.</div></li><li class="half_rhythm"><div>In BFIE seizures start in the first year of life, beyond the neonatal period, and disappear after age one to two years. Seizures are generally brief, lasting two minutes; they appear as daily repeated clusters. Seizure type is usually focal, but can be also generalized, causing diffuse hypertonia with jerks of the limbs, head deviation, or motor arrest with unconsciousness and cyanosis. Infants are normal between seizures and psychomotor development is usually normal.</div></li><li class="half_rhythm"><div>In the <i>KCNQ3</i>-related developmental disability <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, individuals present with intellectual disability with or without seizures and/or cortical visual impairment. As little clinical information on these individuals is available, the clinical presentation of <i>KCNQ3</i>-related developmental disability remains to be defined.</div></li></ul></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of a <i>KCNQ3-</i>related disorder is established in an individual with typical clinical findings and the presence of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KCNQ3</i>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> The seizures of BFNE are generally controlled with antiepileptic drugs (AEDs) including phenobarbital and phenytoin or carbamazepine, which are usually withdrawn at age three to six months. The seizures of BFIE are usually completely controlled with adequate doses of phenobarbital, carbamazepine, or valproate. In the rare instance of seizure recurrence, the starting dose of AED is often low. AEDs are usually withdrawn after one to three years. <i>KCNQ3</i>-related developmental disability is managed using standard evaluations, therapies, and educational support tailored to the individual&#x02019;s needs.</p><p><i>Surveillance:</i> In children with BFNE, EEGs at age three, 12, and 24 months are recommended; the EEG at 24 months should be normal. In children with BFIE, EEGs at onset, 12, 24 and 36 months are recommended; the EEG at 36 months should be normal.</p><p><i>Pregnancy management:</i> The management of a pregnant woman with a <i>KCNQ3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is the same as that for any other pregnant woman with a seizure disorder or at increased risk for a seizure disorder: (a) no AEDs are required if the woman has been seizure-free or if the woman has no history of seizures; and (b) AEDs may be continued for epilepsy that is active during pregnancy.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>The <i>KCNQ3</i>-related disorders BFNE and BFIE are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner and most individuals diagnosed with <i>KCNQ3</i>-related BFNE and <i>KCNQ3</i>-related BFIE have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent or a parent known to have been symptomatic in infancy. In contrast, all individuals with <i>KCNQ3</i>-related developmental disability reported to date have the disorder as the result of a <i>de novo KCNQ3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Each child of an individual with BFNE or BFIE has a 50% chance of inheriting the pathogenic variant. If the <i>KCNQ3</i> pathogenic variant has been identified in an affected family member, prenatal testing for pregnancies at increased risk is possible.</p></div></div><div id="kcnq3-dis.GeneReview_Scope"><h2 id="_kcnq3-dis_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="kcnq3-dis.Td" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK201978/table/kcnq3-dis.Td/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kcnq3-dis.Td_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_kcnq3-dis.Td_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNQ3</i>-Related Disorders: Included Phenotypes&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_kcnq3-dis.Td_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> neonatal epilepsy (BFNE)</div></li><li class="half_rhythm"><div>Benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> infantile epilepsy (BFIE)</div></li><li class="half_rhythm"><div><i>KCNQ3</i>-related developmental disability</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#kcnq3-dis.Nomenclature">Nomenclature</a>.</p></div></dd><dt>1. </dt><dd><div id="kcnq3-dis.TF.d.1"><p class="no_margin">For other genetic causes of these phenotypes see <a href="#kcnq3-dis.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="kcnq3-dis.Diagnosis"><h2 id="_kcnq3-dis_Diagnosis_">Diagnosis</h2><p><i>KCNQ3</i>-related benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> neonatal epilepsy (BFNE) and benign familial infantile epilepsy (BFIE) are epilepsy syndromes associated with a structurally normal brain and mostly normal neurologic findings and psychomotor development. Additionally, pathogenic variants in <i>KCNQ3</i> have been described in individuals with nonfamilial disabilities, including epileptic encephalopathy, intellectual disability apparently without epilepsy, and intellectual disability with seizures and cortical visual impairment.</p><div id="kcnq3-dis.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>KCNQ3</i>-related benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> neonatal epilepsy (BFNE) and benign familial infantile epilepsy (BFIE) <b>should be suspected</b> in individuals with the following findings.</p><p><b>Benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> neonatal epilepsy (BFNE)</b></p><ul><li class="half_rhythm"><div>Seizures starting in an otherwise healthy infant between days two and eight of life and spontaneously disappearing between the first and the sixth to12th month of life</div></li><li class="half_rhythm"><div>Normal physical examination and laboratory tests prior to onset of seizures, between seizure episodes, and following cessation of seizures</div></li><li class="half_rhythm"><div>No specific EEG criteria, but EEG background is normal or near normal for age</div></li><li class="half_rhythm"><div>Family history of the same findings usually present</div></li></ul><p>Seizure features include the following [<a class="bk_pop" href="#kcnq3-dis.REF.ilae.1989.389">ILAE 1989</a>, <a class="bk_pop" href="#kcnq3-dis.REF.ronen.1993.1355">Ronen et al 1993</a>, <a class="bk_pop" href="#kcnq3-dis.REF.engel.2001.796">Engel 2001</a>]:</p><ul><li class="half_rhythm"><div>A wide spectrum of seizure types, encompassing tonic or apneic episodes, focal tonic (stiffening) or clonic (rhythmic shaking) activity, or autonomic changes</div></li><li class="half_rhythm"><div>Motor activity that may be confined to one body part, migrate to other body regions, or generalize</div></li><li class="half_rhythm"><div>Seizures that are usually brief, lasting one to two minutes</div></li><li class="half_rhythm"><div>Infants who are well between seizures and feed normally</div></li><li class="half_rhythm"><div>Interictal EEG that may be normal</div></li><li class="half_rhythm"><div>Ictal EEG showing focal onset with possible secondary generalization</div></li></ul><p>The diagnosis of <i>KCNQ3</i>-related BFNE is suspected in individuals with clinical findings consistent with BFNE and normal results on testing of <i>KCNQ2</i>, the main <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> for BFNE (see <a href="/books/n/gene/bfns/"><i>KCNQ2</i>-Related Disorders</a>).</p><p><b>Benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> infantile epilepsy (BFIE)</b></p><ul><li class="half_rhythm"><div>Brief, repeated, focal, and secondarily generalized seizures occur in otherwise healthy infants; seizures occur in a rather wide time frame in the first year of life beyond the neonatal period.</div></li><li class="half_rhythm"><div>Seizures spontaneously disappear after age 1-2 years without neurologic sequelae in adulthood.</div></li><li class="half_rhythm"><div>Family history of the same findings is usually present.</div></li></ul><p>The diagnosis of <i>KCNQ3</i>-related BFIE is suspected in individuals with clinical findings consistent with BFIE and normal results on testing of <i>PRRT2</i>, the main <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> for BFIE (see <a href="/books/n/gene/prrt2-parox/"><i>PRRT2</i>-Associated Paroxysmal Movement Disorders</a>).</p><p><b>Developmental disability,</b> which can present as one or more of the following:</p><ul><li class="half_rhythm"><div>Epileptic encephalopathy, in which aggressive epileptogenic activity during brain maturation triggers progressive cognitive and neuropsychological deterioration or regression</div></li><li class="half_rhythm"><div>Intellectual disability apparently without epilepsy</div></li><li class="half_rhythm"><div>Intellectual disability with seizures and cortical visual impairment</div></li></ul><p>Note: A few individuals presenting with the developmental disability phenotypes and a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KCNQ3</i> have been described in the literature. So far, very little clinical information on these individuals is available; thus, the clinical presentation of <i>KCNQ3</i>-related developmental disability remains to be defined.</p></div><div id="kcnq3-dis.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of a <i>KCNQ3</i>-related disorder <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical <a href="#kcnq3-dis.Suggestive_Findings">clinical findings</a> and the identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KCNQ3</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK201978/table/kcnq3-dis.T.molecular_genetic_testing_us/?report=objectonly" target="object" rid-figpopup="figkcnq3disTmoleculargenetictestingus" rid-ob="figobkcnq3disTmoleculargenetictestingus">Table 1</a>).</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing or a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (comprehensive genomic sequencing) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Individuals with the distinctive findings of benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> neonatal epilepsy (BFNE) or benign familial infantile epilepsy (BFIE) as described in <a href="#kcnq3-dis.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#kcnq3-dis.Option_1">Option 1</a>). Because the phenotypic range of the <i>KCNQ3</i>-related developmental disorders is, at present, broad and somewhat nonspecific, this is more likely to be diagnosed using genomic testing (see <a href="#kcnq3-dis.Option_2">Option 2</a>).</p><div id="kcnq3-dis.Option_1"><h4>Option 1</h4><p>When the phenotypic and laboratory findings suggest the diagnosis of <i>KCNQ3</i>-related BFNE or BFIE, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>.</p><p><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> This approach could be used for individuals who present with the BFNE or BFIE <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and have previously tested negative for pathogenic variants in <a href="/books/n/gene/bfns/"><i>KCNQ2</i></a> or <a href="/books/n/gene/prrt2-parox/"><i>PRRT2</i></a>, respectively. Sequence analysis of <i>KCNQ3</i> is performed first, and followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</p><ul><li class="half_rhythm"><div>Note: <i>KCNQ3-</i>related disorders have to date been associated in nearly all cases with <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants. A large intragenic <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> has been reported in only one family with BFNE [<a class="bk_pop" href="#kcnq3-dis.REF.sands.2016.2019">Sands et al 2016</a>] ; therefore, testing for intragenic deletions or <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> is unlikely to identify a disease-causing variant.</div></li></ul><p>For those who have had no previous <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, the authors recommend using a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> or more comprehensive testing whenever possible, given the lack of features to distinguish between the different <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-related forms of BFNE and BFIE.</p><p>For an individual with developmental delay, there are no features to distinguish <i>KCNQ3</i>-related developmental disability from the same findings associated with any one of numerous other genes; thus, single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing is not recommended.</p><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>KCNQ3</i> and other genes of interest (see <a href="#kcnq3-dis.Differential_Diagnosis">Differential Diagnosis</a>) may be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p></div><div id="kcnq3-dis.Option_2"><h4>Option 2</h4><p>When the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is indistinguishable from many other inherited disorders with developmental disability, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (comprehensive genomic sequencing; recommended) and/or <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>; to consider).</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when clinically available) includes <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>.</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> for disorders associated with developmental disability that includes <i>KCNQ3</i> and other genes of interest (see <a href="#kcnq3-dis.Differential_Diagnosis">Differential Diagnosis</a>) may be considered; however, given the rarity of <i>KCNQ3</i>-related disorder, many panels for developmental disability may not include this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</div></li></ul><div id="kcnq3-dis.T.molecular_genetic_testing_us" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>KCNQ3</i>-Related Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK201978/table/kcnq3-dis.T.molecular_genetic_testing_us/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kcnq3-dis.T.molecular_genetic_testing_us_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_kcnq3-dis.T.molecular_genetic_testing_us_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_kcnq3-dis.T.molecular_genetic_testing_us_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_kcnq3-dis.T.molecular_genetic_testing_us_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_kcnq3-dis.T.molecular_genetic_testing_us_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNQ3</i></td><td headers="hd_h_kcnq3-dis.T.molecular_genetic_testing_us_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_kcnq3-dis.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">22/23&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_kcnq3-dis.T.molecular_genetic_testing_us_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_kcnq3-dis.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/23&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="kcnq3-dis.TF.1.1"><p class="no_margin">See <a href="/books/n/gene/kcnq3/#kcnq3.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="kcnq3-dis.TF.1.2"><p class="no_margin">See <a href="#kcnq3-dis.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="kcnq3-dis.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="kcnq3-dis.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#kcnq3-dis.REF.charlier.1998.53">Charlier et al [1998]</a>, <a class="bk_pop" href="#kcnq3-dis.REF.hirose.2000.822">Hirose et al [2000]</a>, <a class="bk_pop" href="#kcnq3-dis.REF.singh.2003.2726">Singh et al [2003]</a>, <a class="bk_pop" href="#kcnq3-dis.REF.li.2006.374">Li et al [2006]</a>, <a class="bk_pop" href="#kcnq3-dis.REF.li.2008.1">Li et al [2008]</a>, <a class="bk_pop" href="#kcnq3-dis.REF.neubauer.2008.177">Neubauer et al [2008]</a>, <a class="bk_pop" href="#kcnq3-dis.REF.fister.2013.308">Fister et al [2013]</a>, <a class="bk_pop" href="#kcnq3-dis.REF.zara.2013.425">Zara et al [2013]</a>, <a class="bk_pop" href="#kcnq3-dis.REF.soldovieri.2014.356">Soldovieri et al [2014]</a>, <a class="bk_pop" href="#kcnq3-dis.REF.allen.2014.e99">Allen et al [2014]</a>, <a class="bk_pop" href="#kcnq3-dis.REF.fusco.2015.102">Fusco et al [2015]</a>, <a class="bk_pop" href="#kcnq3-dis.REF.grinton.2015.1071">Grinton et al [2015]</a>, <a class="bk_pop" href="#kcnq3-dis.REF.miceli.2015b.e15">Miceli et al [2015b]</a>, <a class="bk_pop" href="#kcnq3-dis.REF.maljevic.2016.189">Maljevic et al [2016]</a>, <a class="bk_pop" href="#kcnq3-dis.REF.millichap.2016.e96">Millichap et al [2016]</a>, <a class="bk_pop" href="#kcnq3-dis.REF.sands.2016.2019">Sands et al [2016]</a>, <a class="bk_pop" href="#kcnq3-dis.REF.olson.2017.419">Olson et al [2017]</a></p></div></dd><dt>5. </dt><dd><div id="kcnq3-dis.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="kcnq3-dis.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#kcnq3-dis.REF.sands.2016.2019">Sands et al [2016]</a> reported an individual with BFNE who had a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of exons 1-15 in <i>KCNQ3</i>.</p></div></dd></dl></div></div></div></div></div></div><div id="kcnq3-dis.Clinical_Characteristics"><h2 id="_kcnq3-dis_Clinical_Characteristics_">Clinical Characteristics</h2><div id="kcnq3-dis.Clinical_Description"><h3>Clinical Description</h3><p>The <i>KCNQ3</i>-related disorders include benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> neonatal epilepsy (BFNE) and benign familial infantile epilepsy (BFIE), seizure disorders that occur in children who have structurally normal brains, normal interictal neurologic examinations, and normal psychomotor development. A more recently reported <i>KCNQ3</i>-related disorder is associated with a developmental disability <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p><b><i>KCNQ3</i>-related benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> neonatal epilepsy (BFNE)</b> is characterized by seizures that start in an otherwise healthy infant between days two and eight of life and spontaneously disappear between age one month and age six to 12 months. Seizures are generally brief, lasting one to two minutes. Seizure types include tonic or apneic episodes, focal clonic activity, and autonomic changes. Motor activity may be confined to one body part, migrate to other regions, or generalize.</p><p>Infants are well between seizures and feed normally. Psychomotor development is usually normal. However, two individuals within the family with <i>KCNQ3</i>-related BFNE described by <a class="bk_pop" href="#kcnq3-dis.REF.soldovieri.2014.356">Soldovieri et al [2014]</a> and three individuals in the family described by <a class="bk_pop" href="#kcnq3-dis.REF.miceli.2015b.e15">Miceli et al [2015b]</a> showed (in addition to seizures) intellectual disability. Notably, although intellectual and/or language developmental delay has not been thought characteristic of BFNE, some recent reports highlight evidence for such <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> in <i>KCNQ2</i>-related BFNE pedigrees as well [<a class="bk_pop" href="#kcnq3-dis.REF.millichap.2016.e96">Millichap et al 2016</a>, <a class="bk_pop" href="#kcnq3-dis.REF.al_yazidi.2017">Al Yazidi et al 2017</a>, <a class="bk_pop" href="#kcnq3-dis.REF.hewson.2017.2226">Hewson et al 2017</a>].</p><p><b><i>KCNQ3</i>-related benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> infantile epilepsy (BFIE)</b> is characterized by seizures that start in the first year of life, beyond the neonatal period, and disappear after age one to two years. Seizures are generally brief, lasting about two minutes; they appear as daily repeated clusters. Seizure type is usually focal, but can be also generalized, causing diffuse hypertonia with jerks of the limbs, head deviation, or motor arrest with unconsciousness and cyanosis. Infants are normal between seizures and psychomotor development is usually normal.</p><p><b><i>KCNQ3</i>-related developmental disability.</b> Recent efforts to identify genetic contributions in a diversity of neurodevelopmental disorders using <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> have identified a small number of individuals with <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants in <i>KCNQ3</i> [<a class="bk_pop" href="#kcnq3-dis.REF.allen.2013.217">Allen et al 2013</a>, <a class="bk_pop" href="#kcnq3-dis.REF.mcrae.2017.433">McRae et al 2017</a>]. Very little clinical information on these individuals is provided in these reports, but presentations include epileptic encephalopathy with progressive cognitive and neuropsychological deterioration or regression, intellectual disability without epilpesy, and intellectual disability with seizures and cortical visual impairment.</p><p>Note: During the same recent period, more than 100 individuals with developmental disability and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants in the close homolog, <i>KCNQ2</i>, have been described [<a class="bk_pop" href="#kcnq3-dis.REF.millichap.2016.e96">Millichap et al 2016</a>, <a class="bk_pop" href="#kcnq3-dis.REF.olson.2017.419">Olson et al 2017</a>]. Owing to very low numbers and incomplete phenotypic descriptions available to date, it may be suspected that pathogenic variants in <i>KCNQ3</i> are very rare causes of developmental disability, but more detailed reporting of additional <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals is needed to clarify this.</p></div><div id="kcnq3-dis.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Because relatively few families <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>KCNQ3</i> variant have been reported to date, <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> are difficult to establish. In fact, no obvious phenotypic difference is seen between those families with variants that cause a 20%-40% reduction in KCNQ3 function and those that cause a more than 60% reduction in KCNQ3 function (see <a href="#kcnq3-dis.Molecular_Pathogenesis">Molecular Pathogenesis</a>).</p><p>Notably, four different studies have identified the <a class="figpopup" href="/books/NBK201978/table/kcnq3-dis.T.overview_of_the_available_ge/?report=objectonly" target="object" rid-figpopup="figkcnq3disToverviewoftheavailablege" rid-ob="figobkcnq3disToverviewoftheavailablege">p.Arg230Cys</a> variant in children with developmental disability, apparently both with and without epilepsy [<a class="bk_pop" href="#kcnq3-dis.REF.rauch.2012.1674">Rauch et al 2012</a>, <a class="bk_pop" href="#kcnq3-dis.REF.allen.2013.217">Allen et al 2013</a>, <a class="bk_pop" href="#kcnq3-dis.REF.bosch.2016.660">Bosch et al 2016</a>, <a class="bk_pop" href="#kcnq3-dis.REF.mcrae.2017.433">McRae et al 2017</a>].</p><p>See <a class="figpopup" href="/books/NBK201978/table/kcnq3-dis.T.overview_of_the_available_ge/?report=objectonly" target="object" rid-figpopup="figkcnq3disToverviewoftheavailablege" rid-ob="figobkcnq3disToverviewoftheavailablege">Table 2</a> for available <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> information.</p></div><div id="kcnq3-dis.Penetrance"><h3>Penetrance</h3><p>In <i>KCNQ3</i>-related BFNE, <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is incomplete (0.8-0.85): BFNE is found in 47 of 54 individuals with a <i>KCNQ3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#kcnq3-dis.REF.charlier.1998.53">Charlier et al 1998</a>, <a class="bk_pop" href="#kcnq3-dis.REF.hirose.2000.822">Hirose et al 2000</a>, <a class="bk_pop" href="#kcnq3-dis.REF.singh.2003.2726">Singh et al 2003</a>, <a class="bk_pop" href="#kcnq3-dis.REF.li.2006.374">Li et al 2006</a>, <a class="bk_pop" href="#kcnq3-dis.REF.li.2008.1">Li et al 2008</a>, <a class="bk_pop" href="#kcnq3-dis.REF.neubauer.2008.177">Neubauer et al 2008</a>, <a class="bk_pop" href="#kcnq3-dis.REF.fister.2013.308">Fister et al 2013</a>, <a class="bk_pop" href="#kcnq3-dis.REF.allen.2014.e99">Allen et al 2014</a>, <a class="bk_pop" href="#kcnq3-dis.REF.soldovieri.2014.356">Soldovieri et al 2014</a>, <a class="bk_pop" href="#kcnq3-dis.REF.grinton.2015.1071">Grinton et al 2015</a>, <a class="bk_pop" href="#kcnq3-dis.REF.miceli.2015b.e15">Miceli et al 2015b</a>, <a class="bk_pop" href="#kcnq3-dis.REF.maljevic.2016.189">Maljevic et al 2016</a>, <a class="bk_pop" href="#kcnq3-dis.REF.sands.2016.2019">Sands et al 2016</a>].</p><p>The finding of incomplete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in <i>KCNQ3</i>-related BFNE and BFIE may result from failure to recognize the seizures (which can be brief and disappear spontaneously very soon after onset) in some individuals.</p><p>Penetrance has not been studied in <i>KCNQ3</i>-related developmental disability as few individuals have been reported, and those reported have had a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. As in other severe developmental disorders, including <i>KCNQ2</i>-related epileptic encephalopathy, pathogenic variants are judged likely to be fully penetrant. Evidence for this comes by analogy from <i>KCNQ2</i> pedigrees where parents who have postzygotic <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for a pathogenic variant are asymptomatic or have mild symptoms similar to BFNE, but their <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> offspring have epileptic encephalopathy [<a class="bk_pop" href="#kcnq3-dis.REF.weckhuysen.2012.15">Weckhuysen et al 2012</a>, <a class="bk_pop" href="#kcnq3-dis.REF.milh.2015.2314">Milh et al 2015</a>].</p></div><div id="kcnq3-dis.Nomenclature"><h3>Nomenclature</h3><p><a class="bk_pop" href="#kcnq3-dis.REF.rett.1964.609">Rett &#x00026; Teubel [1964]</a> were the first to report <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> occurrence of neonatal seizures of presumed genetic (rather than acquired) origin. To highlight the mostly favorable outcome of the syndrome, the term "benign" was added to "familial neonatal convulsions" four years later by <a class="bk_pop" href="#kcnq3-dis.REF.bjerre.1968.557">Bjerre &#x00026; Corelius [1968]</a>. Terminology was further revised to benign familial neonatal epilepsy (BFNE) to reflect the fact that the seizures were often focal and for consistency with naming of other epilepsy syndromes [<a class="bk_pop" href="#kcnq3-dis.REF.berg.2010.676">Berg et al 2010</a>].</p></div><div id="kcnq3-dis.Prevalence"><h3>Prevalence</h3><p>Fewer than twenty families with BFNE (54 individuals) with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>KCNQ3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have been reported to date [<a class="bk_pop" href="#kcnq3-dis.REF.charlier.1998.53">Charlier et al 1998</a>, <a class="bk_pop" href="#kcnq3-dis.REF.hirose.2000.822">Hirose et al 2000</a>, <a class="bk_pop" href="#kcnq3-dis.REF.singh.2003.2726">Singh et al 2003</a>, <a class="bk_pop" href="#kcnq3-dis.REF.li.2006.374">Li et al 2006</a>, <a class="bk_pop" href="#kcnq3-dis.REF.li.2008.1">Li et al 2008</a>, <a class="bk_pop" href="#kcnq3-dis.REF.neubauer.2008.177">Neubauer et al 2008</a>, <a class="bk_pop" href="#kcnq3-dis.REF.fister.2013.308">Fister et al 2013</a>, <a class="bk_pop" href="#kcnq3-dis.REF.allen.2014.e99">Allen et al 2014</a>, <a class="bk_pop" href="#kcnq3-dis.REF.soldovieri.2014.356">Soldovieri et al 2014</a>, <a class="bk_pop" href="#kcnq3-dis.REF.grinton.2015.1071">Grinton et al 2015</a>, <a class="bk_pop" href="#kcnq3-dis.REF.miceli.2015b.e15">Miceli et al 2015b</a>, <a class="bk_pop" href="#kcnq3-dis.REF.maljevic.2016.189">Maljevic et al 2016</a>, <a class="bk_pop" href="#kcnq3-dis.REF.sands.2016.2019">Sands et al 2016</a>].</p><p>Only three families with BFIE (7 individuals) with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>KCNQ3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have been reported to date [<a class="bk_pop" href="#kcnq3-dis.REF.singh.2003.2726">Singh et al 2003</a>, <a class="bk_pop" href="#kcnq3-dis.REF.zara.2013.425">Zara et al 2013</a>, <a class="bk_pop" href="#kcnq3-dis.REF.fusco.2015.102">Fusco et al 2015</a>].</p><p>The percentage of families with BFNE who have pathogenic variants in <i>KCNQ3</i> is likely less than 5%, as <i>KCNQ2</i> is the main <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> for BFNE, accounting for more than 70% of cases (see <a href="/books/n/gene/bfns/"><i>KCNQ2</i>-Related Disorders</a>). No data on the prevalence of <i>KCNQ3</i> pathogenic variants in BFIE are available; nevertheless, this figure is likely to be small given that another <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> (<i>PRRT2</i>) is the main locus for BFIE.</p></div></div><div id="kcnq3-dis.Genetically_Related_Allelic_Di"><h2 id="_kcnq3-dis_Genetically_Related_Allelic_Di_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>KCNQ3.</i></p></div><div id="kcnq3-dis.Differential_Diagnosis"><h2 id="_kcnq3-dis_Differential_Diagnosis_">Differential Diagnosis</h2><p>The differential diagnosis of <i>KCNQ3</i>-related neurologic disorders includes the differential diagnosis for <a href="#kcnq3-dis.Benign_Familial_Neonatal_Epile">benign familial neonatal epilepsy</a> (BFNE), <a href="#kcnq3-dis.Benign_Familial_Infantile_Epil">benign familial infantile epilepsy</a> (BFIE), and <a href="#kcnq3-dis.Developmental_Disability">developmental disability</a>.</p><div id="kcnq3-dis.Benign_Familial_Neonatal_Epile"><h3>Benign Familial Neonatal Epilepsy (BFNE)</h3><p>The diagnosis of BFNE requires the absence of any other explanation for the seizures. No specific EEG trait characterizes BFNE during neonatal seizures; the interictal EEG is most commonly normal (50%-70% of infants).</p><p><b>Laboratory tests and imaging studies</b> are important to exclude other possible causes for the seizures including those without a genetic etiology. It is important not to miss a diagnosis of a treatable meningoencephalitis in the early stages or of intracranial hemorrhage &#x02013; for either, neonates do not exhibit the typical findings observed in older infants and children, and seizures may be the only early manifestation.</p><p>The following laboratory, imaging, and instrumental studies may be helpful for the differential diagnosis.</p><p>To detect infection or bleeding disorder:</p><ul><li class="half_rhythm"><div><b>Basic hematologic labs.</b> CBC, prothrombin time, activated partial thromboplastin time</div></li><li class="half_rhythm"><div><b>Lumbar puncture.</b> Cerebrospinal fluid examination to exclude neonatal meningoencephalitis or occult blood</div></li><li class="half_rhythm"><div><b>MRI or CT scan of the brain.</b> One or both of these tests should be performed in every individual with neonatal seizures to exclude structural lesions and intracranial hemorrhage.</div></li></ul><p>To detect a biochemical disorder:</p><ul><li class="half_rhythm"><div>Basic metabolic panel plus serum concentration of calcium, magnesium, phosphorus</div></li><li class="half_rhythm"><div>Evaluation of alpha-AASA levels in serum and urine as a biomarker of <a href="/books/n/gene/pds/">pyridoxine (vitamin B<sub>6</sub>)-dependent seizures</a>, a rare genetic disorder of vitamin B<sub>6</sub> metabolism caused by pathogenic variants in <i>ALDH7A1</i> and characterized by neonatal-onset seizures that are resistant to common anticonvulsants, but controlled by daily treatment with vitamin B<sub>6</sub></div></li><li class="half_rhythm"><div>Thyroid function tests, as neonatal hyperthyroid state and thyrotoxicosis may be associated with excessive tremor and jitteriness &#x02012; clinical conditions which should be differentiated from seizures</div></li></ul><p><b>Genetic testing.</b> The most common cause of BFNE is a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KCNQ2</i> which &#x02013; like <i>KCNQ3</i> &#x02013; encodes voltage-gated potassium channel subunits (see <a href="/books/n/gene/bfns/"><i>KCNQ2</i>-Related Disorders</a>). The frequency of <i>KCNQ2</i> pathogenic variants as a cause of BFNE is more than tenfold that of <i>KCNQ3</i> pathogenic variants.</p><p>Because the clinical characteristics of BFNE caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> of <i>KCNQ2</i> or <i>KCNQ3</i> do not appear to differ, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of both genes is commonly performed when BFNE is suspected.</p></div><div id="kcnq3-dis.Benign_Familial_Infantile_Epil"><h3>Benign Familial Infantile Epilepsy (BFIE)</h3><p>BFIE is genetically distinct from BFNE, with at least three loci additional to <i>KCNQ3</i> being involved.</p><ul><li class="half_rhythm"><div>In the largest fraction of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> families, the associated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is <i>PRRT2</i>, a presynaptic protein interacting with SNAP-25 [<a class="bk_pop" href="#kcnq3-dis.REF.heron.2012.152">Heron et al 2012</a>, <a class="bk_pop" href="#kcnq3-dis.REF.zara.2013.425">Zara et al 2013</a>] (see <a href="/books/n/gene/prrt2-parox/"><i>PRRT2</i>-Associated Paroxysmal Movement Disorders</a>). Whereas some patients with pathogenic variants in <i>PRRT2</i> develop paroxysmal kinesigenic dyskinesia later in life, clinical characteristics early in life do not differ from BFIE caused by pathogenic variants in <i>KCNQ3</i>.</div></li><li class="half_rhythm"><div>Less commonly, the associated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is <i>SCN2A</i>, encoding one of the main pore-forming subunits of neuronal voltage-gated sodium channels [<a class="bk_pop" href="#kcnq3-dis.REF.striano.2006.218">Striano et al 2006</a>] (OMIM <a href="http://omim.org/entry/607745" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">607745</a>). The clinical characteristics do not differ from those of <i>KCNQ3</i>-related BFIE.</div></li><li class="half_rhythm"><div>Additional families with a comparable <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> show linkage to 19q12-q13.1 [<a class="bk_pop" href="#kcnq3-dis.REF.guipponi.1997.473">Guipponi et al 1997</a>]. The responsible <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is as yet unknown.</div></li></ul></div><div id="kcnq3-dis.Developmental_Disability"><h3>Developmental Disability</h3><p>Phenotypic features associated with <i>KCNQ3</i> pathogenic variants are so far not sufficiently defined to diagnose a <i>KCNQ3</i>-related disorder with a developmental disability <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Therefore, all genes known to be associated with developmental disability (&#x0003e;180 have been identified) should be included in the differential diagnosis of <i>KCNQ3</i>-related disorders. Since the pathogenic variants associated with this specific <i>KCNQ3</i>-related phenotype are <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> (and thus have a negative family history), all inheritance patterns of developmental disability could be possible. See OMIM Phenotypic Series:</p><ul><li class="half_rhythm"><div><a href="https://omim.org/phenotypicSeries/PS156200" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Intellectual disability, autosomal dominant</a></div></li><li class="half_rhythm"><div><a href="https://omim.org/phenotypicSeries/PS249500" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Intellectual disability, autosomal recessive</a></div></li><li class="half_rhythm"><div><a href="https://omim.org/phenotypicSeries/PS309530" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Intellectual disability, nonsyndromic, X-linked</a></div></li></ul></div></div><div id="kcnq3-dis.Management"><h2 id="_kcnq3-dis_Management_">Management</h2><div id="kcnq3-dis.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with a <i>KCNQ3</i>-related disorder, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>In-depth neurologic examination</div></li><li class="half_rhythm"><div>Developmental evaluation</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="kcnq3-dis.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> neonatal epilepsy (BFNE).</b> The seizures of BFNE are generally controlled with conventional antiepileptic treatment. Phenobarbital and phenytoin (loading doses of 15-20 mg/kg; maintenance doses of 3-4 mg/kg for both agents) [<a class="bk_pop" href="#kcnq3-dis.REF.painter.1981.1107">Painter et al 1981</a>] are the antiepileptic drugs (AEDs) most commonly used to treat neonatal seizures.</p><p>Because of concerns over the suboptimal effectiveness and safety of phenytoin and phenobarbital, other anticonvulsants (e.g., levetiracetam and topiramate) are often used in neonates with refractory seizures, despite limited data and off-label use [<a class="bk_pop" href="#kcnq3-dis.REF.tulloch.2012.31">Tulloch et al 2012</a>]. However, refractory seizures are uncommon in <i>KCNQ3</i>-related BFNE.</p><p>A recent study has been performed to evaluate treatment responses in a small cohort of 19 individuals presenting with clinical features suggestive of BFNE. All but three had family histories of neonatal seizures. Of the 19 individuals, pathogenic variants in <i>KCNQ2</i> were found in 14; pathogenic variants in <i>KCNQ3</i> were present in two. Seventeen (88%) of 19 individuals were seizure free within hours of receiving oral carbamazepine (CBZ) or oxcarbazepine (OXC). Earlier initiation of CBZ was associated with shorter hospitalization. No side effects of CBZ were reported. All individuals had normal development and remain seizure free at a mean follow-up period of six months to 16 years (mean: 7.8 years). The authors concluded that CBZ is safe and rapidly effective in neonates with BFNE, even in status epilepticus, and that CBZ should be the drug of choice in benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> neonatal seizures [<a class="bk_pop" href="#kcnq3-dis.REF.sands.2016.2019">Sands et al 2016</a>].</p><p>Interictal EEG is generally normal and does not influence treatment duration.</p><p>Antiepileptic drugs are usually withdrawn at age three to six months.</p><p><b>Benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> infantile epilepsy (BFIE).</b> The seizures of BFIE are usually completely controlled with the AEDs phenobarbital, carbamazepine, or valproate. If adequately treated, very few individuals show recurrent seizures; seizure recurrence is often caused by a low starting dose of AEDs.</p><p>Antiepileptic medication is usually withdrawn after one to three years with no relapses.</p><div id="kcnq3-dis.Developmental_Delay__Intellect"><h4>Developmental Delay / Intellectual Disability Management Issues</h4><p>The following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country.</p><p><b>Ages 0-3 years.</b> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the US, early intervention is a federally funded program available in all states.</p><p><b>Ages 3-5 years.</b> In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed.</p><p><b>Ages 5-21 years</b></p><ul><li class="half_rhythm"><div>In the US, an IEP based on the individual&#x02019;s level of function should be developed by the local public school district. Affected children are permitted to remain in the public school district until age 21.</div></li><li class="half_rhythm"><div>Discussion about transition plans including financial, vocation/employment, and medical arrangements should begin at age 12 years. Developmental pediatricians can provide assistance with transition to adulthood.</div></li></ul><p><b>All ages.</b> Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life.</p><p>Consideration of private supportive therapies based on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's needs is recommended. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</p><p>In the US:</p><ul><li class="half_rhythm"><div>Developmental Disabilities Administration (DDA) enrollment is recommended. DDA is a public agency that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</div></li><li class="half_rhythm"><div>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</div></li></ul></div><div id="kcnq3-dis.Motor_Dysfunction"><h4>Motor Dysfunction</h4><p><b>Gross motor dysfunction</b></p><ul><li class="half_rhythm"><div>Physical therapy is recommended to maximize mobility and to reduce the risk for later-onset orthopedic complications (e.g., contractures, scoliosis, hip dislocation).</div></li><li class="half_rhythm"><div>Consider use of durable medical equipment as needed (e.g., wheelchairs, walkers, bath chairs, orthotics, adaptive strollers).</div></li><li class="half_rhythm"><div>For muscle tone abnormalities including hypertonia or dystonia, consider involving appropriate specialists to aid in management of baclofen, Botox<sup>&#x000ae;</sup>, anti-parkinsonian medications, or orthopedic procedures.</div></li></ul><p><b>Fine motor dysfunction.</b> Occupational therapy is recommended for difficulty with fine motor skills that affect adaptive function such as feeding, grooming, dressing, and writing.</p><p><b>Oral motor dysfunction.</b> Assuming that the individual is safe to eat by mouth, feeding therapy &#x02013; typically from an occupational or speech therapist &#x02013; is recommended for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who have difficulty feeding due to poor oral motor control.</p><p><b>Communication issues.</b> Consider evaluation for alternative means of communication (e.g., <a href="http://www.asha.org/NJC/AAC/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Augmentative and Alternative Communication</a>) for individuals who have expressive language difficulties.</p></div><div id="kcnq3-dis.SocialBehavioral_Concerns"><h4>Social/Behavioral Concerns</h4><p>Children may qualify for and benefit from interventions used in treatment of autism spectrum disorder, including applied behavior analysis (ABA). ABA therapy is targeted to the individual child&#x02019;s behavioral, social, and adaptive strengths and weaknesses and is typically performed one on one with a board-certified behavior analyst.</p><p>Consultation with a developmental pediatrician may be helpful in guiding parents through appropriate behavior management strategies or providing prescription medications when necessary.</p><p>Concerns about serious aggressive or destructive behavior can be addressed by a pediatric psychiatrist.</p></div></div><div id="kcnq3-dis.Prevention_of_Secondary_Compli"><h3>Prevention of Secondary Complications</h3><p>The potential complications of the disease treatment are those related to AED use.</p></div><div id="kcnq3-dis.Surveillance"><h3>Surveillance</h3><p><b>BFNE.</b> EEG at onset, age three, 12, and 24 months is recommended. The EEG at 24 months should be normal.</p><p><b>BFIE.</b> EEG at onset, 12, 24, and 36 months is recommended. The EEG at 36 months should be normal.</p></div><div id="kcnq3-dis.Evaluation_of_Relatives_at_Ris"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#kcnq3-dis.Related_Genetic_Counseling_Iss">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="kcnq3-dis.Pregnancy_Management"><h3>Pregnancy Management</h3><p>The management of a pregnant woman with a <i>KCNQ3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is the same as that of any other pregnant woman with a history of (or at risk for) epilepsy:</p><ul><li class="half_rhythm"><div>No medication is indicated if (a) the woman has been seizure free and is not taking medication or (b) the woman has no history of seizures.</div></li><li class="half_rhythm"><div>Antiepileptic drug treatment may be continued for active epilepsy during pregnancy.</div></li><li class="half_rhythm"><div>In general, women with epilepsy or a seizure disorder from any cause are at greater risk for mortality during pregnancy than pregnant women without a seizure disorder; use of antiepileptic medication during pregnancy reduces this risk. However, exposure to antiepileptic medication may increase the risk for adverse fetal outcome (depending on the drug used, the dose, and the stage of pregnancy at which medication is taken). Nevertheless, the risk of an adverse outcome to the fetus from antiepileptic medication exposure is often less than that associated with exposure to an untreated maternal seizure disorder. Therefore, use of antiepileptic medication to treat a maternal seizure disorder during pregnancy is typically recommended. Discussion of the risks and benefits of using a given antiepileptic drug during pregnancy should ideally take place prior to conception. Transitioning to a lower-risk medication prior to pregnancy may be possible [<a href="https://www.ncbi.nlm.nih.gov/books/NBK1293/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Sarma et al 2016</a>].</div></li><li class="half_rhythm"><div>See <a href="http://www.mothertobaby.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MotherToBaby</a> for more information on medication use during pregnancy.</div></li></ul></div><div id="kcnq3-dis.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>The selective neuronal KCNQ potassium channel opener ezogabine (US-approved name; retigabine in the EU and Canada), an AED introduced in 2013 as adjunctive treatment of partial epilepsy in adults [<a class="bk_pop" href="#kcnq3-dis.REF.porter.2012.103">Porter et al 2012</a>], may represent a targeted therapy for <i>KCNQ3</i>-related seizures arising from variants that reduce channel activity. However, the discovery of additional side effects in the early post-marketing studies (blue discoloration of skin and retina) raised concerns about its use in children. Ezogabine has been <a href="https://assets.publishing.service.gov.uk/media/57fe4b6640f0b6713800000c/Trobalt_letter.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">commercially withdrawn</a> as of June 2017.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="kcnq3-dis.Genetic_Counseling"><h2 id="_kcnq3-dis_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="kcnq3-dis.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>The <i>KCNQ3</i>-related disorders benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> neonatal epilepsy (BFNE) and benign familial infantile epilepsy (BFIE) are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. To date, all known cases of the <i>KCNQ3</i>-related developmental disability <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> have been associated with <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants.</p></div><div id="kcnq3-dis.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals diagnosed with <i>KCNQ3</i>-related BFNE and <i>KCNQ3</i>-related BFIE have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent or a parent who is known to have been symptomatic in infancy. Of note, parents can be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>KCNQ3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> but have never been symptomatic, given that <a href="#kcnq3-dis.Penetrance">penetrance</a> is incomplete or neonatal seizures may have been unrecognized as they are typically brief and disappear spontaneously soon after onset.</div></li><li class="half_rhythm"><div>In contrast, to date, individuals with <i>KCNQ3</i>-related developmental disability have the disorder as the result of a <i>de novo KCNQ3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the <i>KCNQ3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband, <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent, or low-level postzygotic mosaicism in the parent below the <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the test.</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with <i>KCNQ3</i>-related BFNE and <i>KCNQ3</i>-related BFIE may appear to be negative because of failure to recognize the disorder in family members and/or reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>. An initial, apparently negative family history may be regarded as uncertain until additional efforts are made to determine the early history of each parent including review of parents&#x02019; medical records, and, if possible, consultation with older relatives to determine if the parent was <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> in infancy (but was unaware of the diagnosis as the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> did not persist beyond infancy). Therefore, an apparently negative family history for a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <i>KCNQ3</i>-related BFNE and <i>KCNQ3</i>-related BFIE cannot be confirmed unless <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the proband.</div></li><li class="half_rhythm"><div>Note: If the parent is the individual in whom the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred, s/he may have postzygotic <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for the variant and may be mildly/minimally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or asymptomatic. While this has been reported in <i>KCNQ2</i>-related BFNE [<a class="bk_pop" href="#kcnq3-dis.REF.weckhuysen.2012.15">Weckhuysen et al 2012</a>, <a class="bk_pop" href="#kcnq3-dis.REF.milh.2015.2314">Milh et al 2015</a>], it has not been found in <i>KCNQ3</i>-related disorders to date.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband&#x02019;s parents.</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk to the sibs is 50%. Given the rarity of the disease, little is known about the inter- and intrafamilial phenotypic variability. In most families with <i>KCNQ3</i> pathogenic variants, affected members showed a benign disease course. However, in the family described by <a class="bk_pop" href="#kcnq3-dis.REF.soldovieri.2014.356">Soldovieri et al [2014]</a> febrile seizures beyond the neonatal period and intellectual deficiency occurred in two of the four affected family members, and in the family described by <a class="bk_pop" href="#kcnq3-dis.REF.miceli.2015b.e15">Miceli et al [2015b]</a> three of the four affected individuals showed intellectual deficits in addition to seizures.</div></li><li class="half_rhythm"><div>If the parents have been tested for the <i>KCNQ3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> and:</div><ul><li class="half_rhythm"><div>A parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has the <i>KCNQ3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of inheriting the variant is 50%.</div></li><li class="half_rhythm"><div>The <i>KCNQ3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the empiric <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is approximately 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul></li><li class="half_rhythm"><div>If the parents have not been tested for the <i>KCNQ3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> but are clinically unaffected (and are known not to have been <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> in infancy or childhood), the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low. The sibs of a proband with clinically unaffected parents are still at increased risk for a <i>KCNQ3</i>-related disorder because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a parent or the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> or low-level postzygotic <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with a <i>KCNQ3-</i>related disorder has a 50% chance of inheriting the <i>KCNQ3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Given the rarity of the disease, little is known about the inter- and intrafamilial phenotypic variability.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <i>KCNQ3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="kcnq3-dis.Related_Genetic_Counseling_Iss"><h3>Related Genetic Counseling Issues</h3><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="kcnq3-dis.Prenatal_Testing_and_Preimplan"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>KCNQ3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="kcnq3-dis.Resources"><h2 id="_kcnq3-dis_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>American Epilepsy Society (AES)</b></div><div><a href="http://www.aesnet.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.aesnet.org</a></div></li><li class="half_rhythm"><div><b>Epilepsy Foundation</b></div><div>8301 Professional Place East</div><div>Suite 200</div><div>Landover MD 20785-7223</div><div><b>Phone:</b> 800-332-1000 (toll-free)</div><div><b>Email:</b> ContactUs@efa.org</div><div><a href="https://www.epilepsy.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsy.com</a></div></li><li class="half_rhythm"><div><b>The RIKEE Project (Rational Intervention for KCNQ2/3 Epileptic Encephalopathy) Patient Registry</b></div><div><b>Phone:</b> 713-798-3464</div><div><b>Fax:</b> 713-798-3455</div><div><a href="http://www.rikee.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.rikee.org</a></div></li></ul></div><div id="kcnq3-dis.Molecular_Genetics"><h2 id="_kcnq3-dis_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="kcnq3-dis.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>KCNQ3-Related Disorders: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK201978/table/kcnq3-dis.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kcnq3-dis.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_kcnq3-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_kcnq3-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_kcnq3-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_kcnq3-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_kcnq3-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_kcnq3-dis.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_kcnq3-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/3786" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>KCNQ3</i></a></td><td headers="hd_b_kcnq3-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=3786" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">8q24<wbr style="display:inline-block"></wbr>​.22</a></td><td headers="hd_b_kcnq3-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O43525" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Potassium voltage-gated channel subfamily KQT member 3</a></td><td headers="hd_b_kcnq3-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/KCNQ3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNQ3 database</a><br /><a href="http://www.rikee.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RIKEE KCNQ2-5-related illness database</a></td><td headers="hd_b_kcnq3-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=KCNQ3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNQ3</a></td><td headers="hd_b_kcnq3-dis.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=KCNQ3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KCNQ3</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="kcnq3-dis.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="kcnq3-dis.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for KCNQ3-Related Disorders (<a href="/omim/121201,602232" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK201978/table/kcnq3-dis.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kcnq3-dis.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/121201" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">121201</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SEIZURES, BENIGN FAMILIAL NEONATAL, 2; BFNS2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602232" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602232</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 3; KCNQ3</td></tr></tbody></table></div></div><div id="kcnq3-dis.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>The <i>KCNQ</i> potassium channel <a href="https://www.ncbi.nlm.nih.gov/books/n/gene/glossary/def-item/gene/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">gene</a> subfamily consists of five members (<i>KCNQ1-5</i>), each encoding a subunit of a voltage-gated potassium channel. Each subunit shows distinct tissue distribution and subcellular localization, as well as biophysical, pharmacologic, and pathophysiologic properties [<a class="bk_pop" href="#kcnq3-dis.REF.soldovieri.2011.365">Soldovieri et al 2011</a>].</p><p>KCNQ subunits, similar to other voltage-gated potassium channel subunits, include six transmembrane domains, with cytoplasmic N-terminal (short) and C-terminal (longer) regions. In neurons, KCNQ2, KCNQ3, KCNQ4, and KCNQ5 subunits (either as homomultimers or heteromultimers) represent the molecular basis of the M-current (I<sub>KM</sub>), a K<sup>+</sup>-selective, noninactivating, and slowly activating/deactivating current [<a class="bk_pop" href="#kcnq3-dis.REF.brown.1980.673">Brown &#x00026; Adams 1980</a>, <a class="bk_pop" href="#kcnq3-dis.REF.wang.1998.1890">Wang et al 1998</a>], showing a critical role in spike-frequency adaptation and neuronal excitability control.</p><p>In addition to <i>KCNQ3,</i> all other <i>KCNQ</i> genes have a role in human genetic disease:</p><ul><li class="half_rhythm"><div><i>KCNQ1</i>. <a href="/books/n/gene/rws/">Long QT syndrome</a> (LQTS-1) [<a class="bk_pop" href="#kcnq3-dis.REF.wang.1996.17">Wang et al 1996</a>], <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> atrial fibrillation [<a class="bk_pop" href="#kcnq3-dis.REF.chen.2003.251">Chen et al 2003</a>], and the short QT syndrome [<a class="bk_pop" href="#kcnq3-dis.REF.bellocq.2004.2394">Bellocq et al 2004</a>]</div></li><li class="half_rhythm"><div><i>KCNQ2</i>. The main <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> for BFNE, and a common cause for early infantile epileptic encephalopathy (see <a href="/books/n/gene/bfns/"><i>KCNQ2</i>-Related Disorders</a>)</div></li><li class="half_rhythm"><div><i>KCNQ4.</i> Expressed mainly in th<i>e</i> cochlea and central auditory pathways, causing a rare form of nonsyndromic <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> hearing loss (<a href="/books/n/gene/dfna2/">DFNA2</a>) [<a class="bk_pop" href="#kcnq3-dis.REF.kubisch.1999.437">Kubisch et al 1999</a>]</div></li><li class="half_rhythm"><div><i>KCNQ5</i>. Widely distributed in brain, skeletal muscle, and smooth muscle. Pathogenic variants have been found in four unrelated individuals with intellectual disability, two of whom also have epilepsy [<a class="bk_pop" href="#kcnq3-dis.REF.lehman.2017.65">Lehman et al 2017</a>].</div></li></ul><p><b>Gene structure.</b> The human <i>KCNQ3</i> transcript has 16 exons.</p><p>At least four transcript variants are known; their functional roles and differences are unknown.</p><ul><li class="half_rhythm"><div>Transcript variant 1 (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_004519.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_004519.3</a>; 11266 bp) is the predominant isoform, containing 15 exons; it encodes isoform 1 of the KCNQ3 channel, consisting of 872 aa (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_004510.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_004510.1</a>), and is by at least tenfold the most expressed form in all tissues.</div></li><li class="half_rhythm"><div>Several additional minor <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> are generated by combinations of alternative first-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> use and alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> of the 3&#x02019; exons.</div></li></ul><p>For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK201978/#kcnq3-dis.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> The first <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KCNQ3</i> was described in 1998 [<a class="bk_pop" href="#kcnq3-dis.REF.charlier.1998.53">Charlier et al 1998</a>].</p><p><a href="/books/NBK201978/bin/kcnq3-dis-Table3.pdf">Table 2</a> lists the <i>KCNQ3</i> variants associated with the <i>KCNQ3</i>-related seizure disorders provided by the authors. Whenever possible, a short comment on the functional consequences of each variant is given, along with interpretation based on current understanding of the disorder.</p><div id="kcnq3-dis.T.overview_of_the_available_ge" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Overview of the Available Genetic, Clinical, and Functional Data from Families with <i>KCNQ3</i> Variants: BFNE, BFIE and Other Complex Neurologic Phenotypes</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK201978/table/kcnq3-dis.T.overview_of_the_available_ge/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kcnq3-dis.T.overview_of_the_available_ge_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_1" scope="col" rowspan="1" colspan="1" style="background-color:rgb(242,242,242);text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_2" scope="col" rowspan="1" colspan="1" style="background-color:rgb(242,242,242);text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_3" scope="col" rowspan="1" colspan="1" style="background-color:rgb(242,242,242);text-align:left;vertical-align:middle;">Localization</th><th id="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_4" scope="col" rowspan="1" colspan="1" style="background-color:rgb(242,242,242);text-align:left;vertical-align:middle;">BFNE</th><th id="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_5" scope="col" rowspan="1" colspan="1" style="background-color:rgb(242,242,242);text-align:left;vertical-align:middle;">BFIE</th><th id="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_6" scope="col" rowspan="1" colspan="1" style="background-color:rgb(242,242,242);text-align:left;vertical-align:middle;">Additional<br />Clinical Data</th><th id="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_7" scope="col" rowspan="1" colspan="1" style="background-color:rgb(242,242,242);text-align:left;vertical-align:middle;">Functional Effects</th><th id="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_8" scope="col" rowspan="1" colspan="1" style="background-color:rgb(242,242,242);text-align:left;vertical-align:middle;">References</th></tr></thead><tbody><tr><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">c.680G&#x0003e;A</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">p.Arg227Gln</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ID (no details provided)</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kcnq3-dis.REF.mcrae.2017.433">McRae et al [2017]</a></td></tr><tr><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.688C&#x0003e;T</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg230Cys</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">S4</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02012;</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02012;</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant found in 4 unrelated persons, all <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>, in studies focused on different phenotypes:
<ul><li class="half_rhythm"><div>Rauch: nonsyndromic <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> ID</div></li><li class="half_rhythm"><div>Epi4K: epileptic encephalopathy</div></li><li class="half_rhythm"><div>Bosch: ID, cortical visual impairment, &#x00026; absence seizures</div></li><li class="half_rhythm"><div>DDD consortium: ID</div></li></ul>
Phenotypic details not yet available</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Stabilization of the activated state, producing a <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> effect</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kcnq3-dis.REF.rauch.2012.1674">Rauch et al [2012]</a>, <a class="bk_pop" href="#kcnq3-dis.REF.allen.2013.217">Allen et al [2013]</a>, <a class="bk_pop" href="#kcnq3-dis.REF.bosch.2016.660">Bosch et al [2016]</a>, <a class="bk_pop" href="#kcnq3-dis.REF.miceli.2015a.3782">Miceli et al [2015a]</a>, <a class="bk_pop" href="#kcnq3-dis.REF.mcrae.2017.433">McRae et al [2017]</a></td></tr><tr><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.835G&#x0003e;T</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val279Phe</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">S5</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02012;</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reduction in current amplitude when expressed w/<i>KCNQ2</i>; no significant difference when expressed w/<i>KCNQ2</i> &#x00026; <i>KCNQ3</i></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kcnq3-dis.REF.maljevic.2016.189">Maljevic et al [2016]</a></td></tr><tr><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.895G&#x0003e;A</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu299Lys</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_3" rowspan="9" colspan="1" style="text-align:left;vertical-align:middle;">S5-S6 linker region; pore</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02012;</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant segregates w/BFNE <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in 4/5 sibs of a 3-generation family; possibly contributes to the rolandic epilepsy in this family.</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reduction in current amplitude</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kcnq3-dis.REF.neubauer.2008.177">Neubauer et al [2008]</a>; <a class="bk_pop" href="#kcnq3-dis.REF.hahn.2009.515">Hahn &#x00026; Neubauer [2009]</a></td></tr><tr><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.914A&#x0003e;G</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp305Gly</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_4" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02012;</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reduced current amplitude of heteromeric channels</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kcnq3-dis.REF.singh.2003.2726">Singh et al [2003]</a></td></tr><tr><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.923G&#x0003e;C</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp308Ser</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_4" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02012;</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mother (not tested) w/neonatal &#x00026; febrile seizures</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kcnq3-dis.REF.sands.2016.2019">Sands et al [2016]</a></td></tr><tr><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.925T&#x0003e;C</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp309Arg</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_4" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02012;</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Homomeric channels lacked potassium current &#x00026; heteromeric channels displayed a dramatic reduction of current.</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kcnq3-dis.REF.hirose.2000.822">Hirose et al [2000]</a>; <a class="bk_pop" href="#kcnq3-dis.REF.uehara.2008.55">Uehara et al [2008]</a>; <a class="bk_pop" href="#kcnq3-dis.REF.sugiura.2009.82">Sugiura et al [2009]</a></td></tr><tr><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.929G&#x0003e;T</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly310Val</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_4" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02012;</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kcnq3-dis.REF.charlier.1998.53">Charlier et al [1998]</a></td></tr><tr><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.950T&#x0003e;C</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile317Thr</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_4" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02012;</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Moderate psychomotor delay in some family members</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reduction in current amplitude</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kcnq3-dis.REF.soldovieri.2014.356">Soldovieri et al [2014]</a></td></tr><tr><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.988C&#x0003e;T</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg330Cys</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_4" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02012;</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Same variant detected in 2 unrelated families</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Homomeric channels lacked potassium current &#x00026; no significant difference in current amplitude when expressed w/KCNQ2 &#x00026; KCNQ3.</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kcnq3-dis.REF.li.2006.374">Li et al [2006]</a>; <a class="bk_pop" href="#kcnq3-dis.REF.li.2008.1">Li et al [2008]</a>; <a class="bk_pop" href="#kcnq3-dis.REF.fister.2013.308">Fister et al [2013]</a>; <a class="bk_pop" href="#kcnq3-dis.REF.miceli.2015b.e15">Miceli et al [2015b]</a></td></tr><tr><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.989G&#x0003e;T</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg330Leu</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_4" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02012;</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Moderate psychomotor delay in several family members</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Homomeric channels lacked potassium current &#x00026; reduction of current amplitude when expressed w/KCNQ2 &#x00026; KCNQ3.</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kcnq3-dis.REF.miceli.2015b.e15">Miceli et al [2015b]</a></td></tr><tr><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.989G&#x0003e;A</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg330His</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_4" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02012;</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kcnq3-dis.REF.allen.2014.e99">Allen et al [2014]</a></td></tr><tr><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1019G&#x0003e;T</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly340Val</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">S6 region</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02012;</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kcnq3-dis.REF.grinton.2015.1071">Grinton et al [2015]</a></td></tr><tr><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1066G&#x0003e;A</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala356Thr</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_4" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">&#x02012;</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02012;</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ID (no details provided)</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kcnq3-dis.REF.mcrae.2017.433">McRae et al [2017]</a></td></tr><tr><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1091G&#x0003e;A</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg364His</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_3" rowspan="9" colspan="1" style="text-align:left;vertical-align:middle;">C-terminus</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02012;</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Late-infantile staring spells at age 2 years, generalized convulsive seizures &#x00026; CTS on EEG</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kcnq3-dis.REF.fusco.2015.102">Fusco et al [2015]</a></td></tr><tr><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1142C&#x0003e;T</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala381Val</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_4" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">&#x02012;</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02012;</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant occurred in 2 sibs w/rolandic epilepsy (no neonatal seizures), but was also present in their unaffected mother; a very rare <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>, absent in the gnomad database of 250K alleles.</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No functional effect; variant of <a class="def" href="/books/n/gene/glossary/def-item/unknown-significance/">unknown significance</a></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kcnq3-dis.REF.neubauer.2008.177">Neubauer et al [2008]</a></td></tr><tr><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1403A&#x0003e;G</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn468Ser</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_4" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">&#x02012;</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">All 3 sibs w/the variant were <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>. Chinese ethnicity; variant is present in 0.06% of East Asians (<a href="http://gnomad.broadinstitute.org/variant/8-133153438-T-C" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">gnomAD</a>)</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No functional effect; variant of unknown signficance &#x02012; although low <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is established, a partial contribution cannot be excluded.</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kcnq3-dis.REF.singh.2003.2726">Singh et al [2003]</a></td></tr><tr><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">c.1657G&#x0003e;A</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">p.Gly553Arg</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_4" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ID (no details provided)</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kcnq3-dis.REF.mcrae.2017.433">McRae et al [2017]</a></td></tr><tr><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1720C&#x0003e;T</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro574Ser</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_4" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02012;</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Allele is present at 0.3% in non-Finnish Europeans &#x00026; 0.2% in Latinos (<a href="http://gnomad.broadinstitute.org/variant/8-133146616-G-A%20" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">gnomAD</a>). Overrepresented (p=0.008) in <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> generalized epilepsies (8/455 persons). Detected in other complex phenotypes; in 4 persons w/rolandic epilepsy &#x00026; in 1 w/rolandic epilepsy &#x00026; moderate psychomotor delay; in 3 persons w/autism spectrum disorders &#x00026; no additional neurologic features</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No functional effect; reduced current amplitude only when coexpressed w/KCNQ5. Variant of unknown signficance &#x02012; although low <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is established, a partial contribution cannot be excluded.</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kcnq3-dis.REF.neubauer.2008.177">Neubauer et al [2008]</a>; <a class="bk_pop" href="#kcnq3-dis.REF.hahn.2009.515">Hahn &#x00026; Neubauer, [2009]</a>; <a class="bk_pop" href="#kcnq3-dis.REF.miceli.2009.501">Miceli et al [2009]</a>; <a class="bk_pop" href="#kcnq3-dis.REF.lemke.2012.1387">Lemke et al [2012]</a>; <a class="bk_pop" href="#kcnq3-dis.REF.gilling.2013.54">Gilling et al [2013]</a></td></tr><tr><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2263G&#x0003e;A</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp755Asn</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_4" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">&#x02012;</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02012;</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant occurred in 2 sibs: 1 w/rolandic epilepsy (no neonatal seizures), 1 w/EEG features (CTS) but no seizures. Also occurred in the unaffected mother &#x00026; was absent in a sib w/rolandic epilepsy; is present in 0.07% of Europeans, incl 1 <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> individual (<a href="http://exac.broadinstitute.org/variant/8-133141865-C-T" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ExAC</a>).</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant of <a class="def" href="/books/n/gene/glossary/def-item/unknown-significance/">unknown significance</a></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kcnq3-dis.REF.neubauer.2008.177">Neubauer et al [2008]</a></td></tr><tr><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2338C&#x0003e;T</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg780Cys</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_4" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">&#x02012;</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kcnq3-dis.REF.zara.2013.425">Zara et al [2013]</a></td></tr><tr><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2462A&#x0003e;G</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn821Ser</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_4" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02012;</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Found in a typical family w/BFNE who also had a <i>KCNQ2</i> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/<a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> (likely pathogenic); the <i>KCNQ3</i> variant does not cosegregate w/the disease.</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No difference versus wt; likely non-<a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kcnq3-dis.REF.bassi.2005.185">Bassi et al [2005]</a></td></tr><tr><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Del ex1-15</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_4" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02012;</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neonatal seizures followed by rolandic epilepsy in <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> &#x00026; maternal grandfather</td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kcnq3-dis.T.overview_of_the_available_ge_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#kcnq3-dis.REF.sands.2016.2019">Sands et al [2016]</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">BFIE = benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> infantile epilepsy; BFNE = benign familial neonatal epilepsy; CTS = centrotemporal spikes; FS = febrile seizures; ID = intellectual disability</p></div></dd><dt></dt><dd><div><p class="no_margin">Reference sequences: <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_004519.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_004519<wbr style="display:inline-block"></wbr>​.3</a> (KCNQ3), <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> numbering begins with +1 as the A of ATG initiation codon.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>KCNQ3</i> encodes a voltage-gated potassium channel subunit (KCNQ3 or Kv7.3) mainly expressed in neurons. KCNQ3 appears unable to form a ion-conducting channel by itself, but must coassemble with KCNQ2, KCNQ4, or KCNQ5.</p><p>KCNQ3/KCNQ2 heteromers are believed to be the main constituents underlying a K<sup>+</sup> current, called M-current, which plays important roles in controlling excitability in many central and peripheral neurons [<a class="bk_pop" href="#kcnq3-dis.REF.delmas.2005.850">Delmas &#x00026; Brown 2005</a>]. M-current activation reduces neuronal excitability by stabilizing the membrane potential at values closer to the equilibrium potential for K<sup>+</sup> ions, thus limiting repetitive firing and contributing to spike frequency adaptation. M-current, somewhat paradoxically, can also augment excitability under some conditions, by enhancing availability of the sodium channels driving the neuronal action potential [<a class="bk_pop" href="#kcnq3-dis.REF.battefeld.2014.3719">Battefeld et al 2014</a>]. M-currents are present on both excitatory principal cells and inhibitory interneurons [<a class="bk_pop" href="#kcnq3-dis.REF.lawrence.2006.12325">Lawrence et al 2006</a>, <a class="bk_pop" href="#kcnq3-dis.REF.battefeld.2014.3719">Battefeld et al 2014</a>]. The complexity of M-current roles, which may change with human development, are factors contributing to the phenotypic heterogeneity and age dependence associated with <i>KCNQ3</i>.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Except for one small <a class="def" href="/books/n/gene/glossary/def-item/pedigree/">pedigree</a> with an intragenic <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> [<a class="bk_pop" href="#kcnq3-dis.REF.sands.2016.2019">Sands et al 2016</a>], all known pedigrees with <i>KCNQ3</i>-related epilepsy have <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants. Heterozygous <i>KCNQ3</i> complete loss may usually be tolerated, since there are 11 <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a>, frame shift, and stop gain variants in the gnomAD control dataset. This stands in contrast to <i>KCNQ2</i>-related BFNE, where about two thirds of pedigrees have large intragenic deletions, splice site, frame shift, and stop gain variants [<a class="bk_pop" href="#kcnq3-dis.REF.millichap.2016.e96">Millichap et al 2016</a>], and only one such <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> (also found in a large BFNE pedigree) is present in gnomAD. Thus, <i>KCNQ3</i> pathogenicity appears usually to result from the expression of variant KCNQ3 subunits that alter the activity of heteromeric channels.</p><p>A series of <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> <i>KCNQ3</i> variants identified in BFNE pedigrees have been shown to reduce KCNQ2/KCNQ3 current, but the quantitative reduction does not appear to strictly correlate with seizure duration or presence of developmental disability. Most BFNE-causing <i>KCNQ3</i> variants (e.g., p.Glu299Lys, p.Asp305Gly, p.Gly310Val, and p.Arg330Cys) caused a 20%-40% reduction in current, but expression of KCNQ3 p.Tyr309Arg reduced heteromeric channel function by about 60%, suggesting a <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> effect. No obvious phenotypic differences were seen between those families. In addition, two <i>KCNQ3</i> variants (p.Arg330Leu and p.Ile317Thr) described in pedigrees including individuals with BFNE symptoms in infancy but subsequent moderate psychomotor delay caused a variable decrease (between 30% and &#x0003e;60%) in aspects of channel function [<a class="bk_pop" href="#kcnq3-dis.REF.soldovieri.2014.356">Soldovieri et al 2014</a>, <a class="bk_pop" href="#kcnq3-dis.REF.miceli.2015b.e15">Miceli et al 2015b</a>].</p><p>The <i>KCNQ3</i> variant p.Arg230Cys, recently identified as occurring <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> in four individuals with phenotypes including epileptic encephalopathy and intellectual disability with or without seizures and cortical visual impairment, is located outside the pore <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, in the voltage-sensor. Functional studies have demonstrated an opposite effect to variants causing BFNE. <i>KCNQ3</i> variant p.Arg230Cys stabilized the channel open state, thereby producing a <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> effect [<a class="bk_pop" href="#kcnq3-dis.REF.miceli.2015a.3782">Miceli et al 2015a</a>]. Owing to small patient numbers, incomplete clinical information, and complex functional profiles of the known <i>KCNQ3</i> variants, definitive conclusions about potential <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> cannot be drawn at this stage.</p></div></div><div id="kcnq3-dis.References"><h2 id="_kcnq3-dis_References_">References</h2><div id="kcnq3-dis.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.allen.2013.217">Allen AS, Berkovic SF, Cossette P, Delanty N, Dlugos D, Eichler EE, Epstein MP, Glauser T, Goldstein DB, Han Y, Heinzen EL, Hitomi Y, Howell KB, Johnson MR, Kuzniecky R, Lowenstein DH, Lu YF, Madou MR, Marson AG, Mefford HC, Esmaeeli Nieh S, O'Brien TJ, Ottman R, Petrovski S, Poduri A, Ruzzo EK, Scheffer IE, Sherr EH, Yuskaitis CJ, Abou-Khalil B, Alldredge BK, Bautista JF, Berkovic SF, Boro A, Cascino GD, Consalvo D, Crumrine P, Devinsky O, Dlugos D, Epstein MP, Fiol M, Fountain NB, French J, Friedman D, Geller EB, Glauser T, Glynn S, Haut SR, Hayward J, Helmers SL, Joshi S, Kanner A, Kirsch HE, Knowlton RC, Kossoff EH, Kuperman R, Kuzniecky R, Lowenstein DH, McGuire SM, Motika PV, Novotny EJ, Ottman R, Paolicchi JM, Parent JM, Park K, Poduri A, Scheffer IE, Shellhaas RA, Sherr EH, Shih JJ, Singh R, Sirven J, Smith MC, Sullivan J, Lin Thio L, Venkat A, Vining EP, Von Allmen GK, Weisenberg JL, Widdess-Walsh P, Winawer MR, et al.  Epi4K Consortium and Epilepsy Phenome/Genome Project: De novo mutations in epileptic encephalopathies. <span><span class="ref-journal">Nature. </span>2013;<span class="ref-vol">501</span>:217–21.</span> [<a href="/pmc/articles/PMC3773011/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3773011</span></a>] [<a href="/pubmed/23934111" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23934111</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.allen.2014.e99">Allen NM, Mannion M, Conroy J, Lynch SA, Shahwan A, Lynch B, King MD. The variable phenotypes of KCNQ-related epilepsy. <span><span class="ref-journal">Epilepsia. </span>2014;<span class="ref-vol">55</span>:e99–105.</span> [<a href="/pubmed/25052858" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25052858</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.al_yazidi.2017">Al Yazidi G, Shevell MI, Srour M. Two novel KCNQ2 mutations in 2 families with benign familial neonatal convulsions. Child Neurol Open. 2017; 4:2329048X17691396. [<a href="/pmc/articles/PMC5417349/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5417349</span></a>] [<a href="/pubmed/28503627" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28503627</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.bassi.2005.185">Bassi MT, Balottin U, Panzeri C, Piccinelli P, Castaldo P, Barrese V, Soldovieri MV, Miceli F, Colombo M, Bresolin N, Borgatti R, Taglialatela M. Functional analysis of novel KCNQ2 and KCNQ3 gene variants found in a large pedigree with benign familial neonatal convulsions (BFNC). <span><span class="ref-journal">Neurogenetics. </span>2005;<span class="ref-vol">6</span>:185–93.</span> [<a href="/pubmed/16235065" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16235065</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.battefeld.2014.3719">Battefeld A, Tran BT, Gavrilis J, Cooper EC, Kole MH. Heteromeric Kv7.2/7.3 channels differentially regulate action potential initiation and conduction in neocortical myelinated axons. <span><span class="ref-journal">J Neurosci. </span>2014;<span class="ref-vol">34</span>:3719–32.</span> [<a href="/pmc/articles/PMC3942587/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3942587</span></a>] [<a href="/pubmed/24599470" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24599470</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.bellocq.2004.2394">Bellocq C, van Ginneken AC, Bezzina CR, Alders M, Escande D, Mannens MM, Bar&#x000f3; I, Wilde AA. Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. <span><span class="ref-journal">Circulation. </span>2004;<span class="ref-vol">109</span>:2394–7.</span> [<a href="/pubmed/15159330" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15159330</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.berg.2010.676">Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, Engel J, French J, Glauser TA, Mathern GW, Mosh&#x000e9; SL, Nordli D, Plouin P, Scheffer IE. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. <span><span class="ref-journal">Epilepsia. </span>2010;<span class="ref-vol">51</span>:676–85.</span> [<a href="/pubmed/20196795" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20196795</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.bjerre.1968.557">Bjerre I, Corelius E. Benign familial neonatal convulsions. <span><span class="ref-journal">Acta Paediatr Scand. </span>1968;<span class="ref-vol">57</span>:557–61.</span> [<a href="/pubmed/5706374" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5706374</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.bosch.2016.660">Bosch DG, Boonstra FN, de Leeuw N, Pfundt R, Nillesen WM, de Ligt J, Gilissen C, Jhangiani S, Lupski JR, Cremers FP, de Vries BB. Novel genetic causes for cerebral visual impairment. <span><span class="ref-journal">Eur J Hum Genet. </span>2016;<span class="ref-vol">24</span>:660–5.</span> [<a href="/pmc/articles/PMC4930090/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4930090</span></a>] [<a href="/pubmed/26350515" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26350515</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.brown.1980.673">Brown DA, Adams PR. Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone. <span><span class="ref-journal">Nature. </span>1980;<span class="ref-vol">283</span>:673–6.</span> [<a href="/pubmed/6965523" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6965523</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.charlier.1998.53">Charlier C, Singh NA, Ryan SG, Lewis TB, Reus BE, Leach RJ, Leppert M. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. <span><span class="ref-journal">Nature Genet. </span>1998;<span class="ref-vol">18</span>:53–5.</span> [<a href="/pubmed/9425900" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9425900</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.chen.2003.251">Chen YH, Xu SJ, Bendahhou S, Wang XL, Wang Y, Xu WY, Jin HW, Sun H, Su XY, Zhuang QN, Yang YQ, Li YB, Liu Y, Xu HJ, Li XF, Ma N, Mou CP, Chen Z, Barhanin J, Huang W. KCNQ1 gain-of-function mutation in familial atrial fibrillation. <span><span class="ref-journal">Science. </span>2003;<span class="ref-vol">299</span>:251–4.</span> [<a href="/pubmed/12522251" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12522251</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.delmas.2005.850">Delmas P, Brown DA. Pathways modulating neural KCNQ/M (Kv7) potassium channels. <span><span class="ref-journal">Nat Rev Neurosci. </span>2005;<span class="ref-vol">6</span>:850–62.</span> [<a href="/pubmed/16261179" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16261179</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.engel.2001.796">Engel J. A Proposed Diagnostic Scheme for People with Epileptic Seizures and with Epilepsy: Report of the ILAE Task Force on Classification and Terminology. <span><span class="ref-journal">Epilepsia. </span>2001;<span class="ref-vol">42</span>:796–803.</span> [<a href="/pubmed/11422340" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11422340</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.fister.2013.308">Fister P, Soltirovska-Salamon A, Debeljak M, Paro-Panjan D. Benign familial neonatal convulsions caused by mutation in KCNQ3, exon 6: A European case. <span><span class="ref-journal">Eur J Paediatr Neurol. </span>2013;<span class="ref-vol">17</span>:308–10.</span> [<a href="/pubmed/23146207" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23146207</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.fusco.2015.102">Fusco C, Frattini D, Bassi MT. A novel KCNQ3 gene mutation in a child with infantile convulsions and partial epilepsy with centrotemporal spikes. <span><span class="ref-journal">Eur J Paediatr Neurol. </span>2015;<span class="ref-vol">19</span>:102–3.</span> [<a href="/pubmed/25278462" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25278462</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.gilling.2013.54">Gilling M, Rasmussen HB, Calloe K, Sequeira AF, Baretto M, Oliveira G, Almeida J, Lauritsen MB, Ullmann R, Boonen SE, Brondum-Nielsen K, Kalscheuer VM, T&#x000fc;mer Z, Vicente AM, Schmitt N, Tommerup N. Dysfunction of the heteromeric KV7.3/KV7.5 potassium channel is associated with autism spectrum disorders. <span><span class="ref-journal">Front Genet. </span>2013;<span class="ref-vol">4</span>:54.</span> [<a href="/pmc/articles/PMC3627139/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3627139</span></a>] [<a href="/pubmed/23596459" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23596459</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.grinton.2015.1071">Grinton BE, Heron SE, Pelekanos JT, Zuberi SM, Kivity S, Afawi Z, Williams TC, Casalaz DM, Yendle S, Linder I, Lev D, Lerman-Sagie T, Malone S, Bassan H, Goldberg-Stern H, Stanley T, Hayman M, Calvert S, Korczyn AD, Shevell M, Scheffer IE, Mulley JC, Berkovic SF. Familial neonatal seizures in 36 families: Clinical and genetic features correlate with outcome. <span><span class="ref-journal">Epilepsia. </span>2015;<span class="ref-vol">56</span>:1071–80.</span> [<a href="/pubmed/25982755" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25982755</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.guipponi.1997.473">Guipponi M, Rivier F, Vigevano F, Beck C, Crespel A, Echenne B, Lucchini P, Sebastianelli R, Baldy-Moulinier M, Malafosse A. Linkage mapping of benign familial infantile convulsions (BFIC) to chromosome 19q. <span><span class="ref-journal">Hum Mol Genet. </span>1997;<span class="ref-vol">6</span>:473–7.</span> [<a href="/pubmed/9147652" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9147652</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.hahn.2009.515">Hahn A, Neubauer BA. Sodium and potassium channel dysfunctions in rare and common idiopathic epilepsy syndromes. <span><span class="ref-journal">Brain Dev. </span>2009;<span class="ref-vol">31</span>:515–20.</span> [<a href="/pubmed/19464834" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19464834</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.heron.2012.152">Heron SE, Grinton BE, Kivity S, Afawi Z, Zuberi SM, Hughes JN, Pridmore C, Hodgson BL, Iona X, Sadleir LG, Pelekanos J, Herlenius E, Goldberg-Stern H, Bassan H, Haan E, Korczyn AD, Gardner AE, Corbett MA, G&#x000e9;cz J, Thomas PQ, Mulley JC, Berkovic SF, Scheffer IE, Dibbens LM. PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">90</span>:152–60.</span> [<a href="/pmc/articles/PMC3257886/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3257886</span></a>] [<a href="/pubmed/22243967" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22243967</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.hewson.2017.2226">Hewson S, Puka K, Mercimek-Mahmutoglu S. Variable expressivity of a likely pathogenic variant in KCNQ2 in a three-generation pedigree presenting with intellectual disability with childhood onset seizures. <span><span class="ref-journal">Am J Med Genet A. </span>2017;<span class="ref-vol">173</span>:2226–30.</span> [<a href="/pubmed/28602030" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28602030</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.hirose.2000.822">Hirose S, Zenri F, Akiyoshi H, Fukuma G, Iwata H, Inoue T, Yonetani M, Tsutsumi M, Muranaka H, Kurokawa T, Hanai T, Wada K, Kaneko S, Mitsudome A. A novel mutation of KCNQ3 (c.925T--&#x0003e;C) in a Japanese family with benign familial neonatal convulsions. <span><span class="ref-journal">Ann Neurol. </span>2000;<span class="ref-vol">47</span>:822–6.</span> [<a href="/pubmed/10852552" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10852552</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.ilae.1989.389">ILAE.  Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and classification of epilepsies and epileptic syndromes. <span><span class="ref-journal">Epilepsia. </span>1989;<span class="ref-vol">30</span>:389–99.</span> [<a href="/pubmed/2502382" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2502382</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.kubisch.1999.437">Kubisch C, Schroeder BC, Friedrich T, L&#x000fc;tjohann B, El-Amraoui A, Marlin S, Petit C, Jentsch TJ. KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. <span><span class="ref-journal">Cell. </span>1999;<span class="ref-vol">96</span>:437–46.</span> [<a href="/pubmed/10025409" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10025409</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.lawrence.2006.12325">Lawrence JJ, Saraga F, Churchill JF, Statland JM, Travis KE, Skinner FK, McBain CJ. Somatodendritic Kv7/KCNQ/M channels control interspike interval in hippocampal interneurons. <span><span class="ref-journal">J Neurosci. </span>2006;<span class="ref-vol">26</span>:12325–38.</span> [<a href="/pmc/articles/PMC6675427/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6675427</span></a>] [<a href="/pubmed/17122058" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17122058</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.lehman.2017.65">Lehman A, Thouta S, Mancini GMS, Naidu S, van Slegtenhorst M, McWalter K, Person R, Mwenifumbo J, Salvarinova R. CAUSES Study; EPGEN Study, Guella I, McKenzie MB, Datta A, Connolly MB, Kalkhoran SM, Poburko D, Friedman JM, Farrer MJ, Demos M, Desai S, Claydon T. Loss-of-function and gain-of-function mutations in KCNQ5 cause intellectual disability or epileptic encephalopathy. <span><span class="ref-journal">Am J Hum Genet. </span>2017;<span class="ref-vol">101</span>:65–74.</span> [<a href="/pmc/articles/PMC5501867/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5501867</span></a>] [<a href="/pubmed/28669405" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28669405</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.lemke.2012.1387">Lemke JR, Riesch E, Scheurenbrand T, Schubach M, Wilhelm C, Steiner I, Hansen J, Courage C, Gallati S, Burki S, Strozzi S, Simonetti BG, Grunt S, Steinlin M, Alber M, Wolff M, Klopstock T, Prott EC, Lorenz R, Spaich C, Rona S, Lakshminarasimhan M, Kroll J, Dorn T, Kramer G, Synofzik M, Becker F, Weber YG, Lerche H, Bohm D, Biskup S. Targeted next generation sequencing as a diagnostic tool in epileptic disorders. <span><span class="ref-journal">Epilepsia. </span>2012;<span class="ref-vol">53</span>:1387–98.</span> [<a href="/pubmed/22612257" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22612257</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.li.2008.1">Li H, Li N, Shen L, Jiang H, Yang Q, Song Y, Guo J, Xia K, Pan Q, Tang B. A novel mutation of KCNQ3 gene in a Chinese family with benign familial neonatal convulsions. <span><span class="ref-journal">Epilepsy Res. </span>2008;<span class="ref-vol">79</span>:1–5.</span> [<a href="/pubmed/18249525" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18249525</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.li.2006.374">Li HY, Tang BS, Yan XX, Guo JF, Shen L, Song YM, Jiang H, Xia K, Xie ZG, Yang QA. Clinical and mutational analysis of KCNQ3 gene in a Chinese family with benign familial neonatal convulsions. <span><span class="ref-journal">Zhonghua Yi Xue Yi Chuan Xue Za Zhi. </span>2006;<span class="ref-vol">23</span>:374–7.</span> [<a href="/pubmed/16883520" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16883520</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.maljevic.2016.189">Maljevic S, Vejzovic S, Bernhard MK, Bertsche A, Weise S, D&#x000f6;cker M, Lerche H, Lemke JR, Merkenschlager A, Syrbe S. Novel KCNQ3 mutation in a large family with benign familial neonatal epilepsy: a rare cause of neonatal seizures. <span><span class="ref-journal">Mol Syndromol. </span>2016;<span class="ref-vol">7</span>:189–196.</span> [<a href="/pmc/articles/PMC5073621/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5073621</span></a>] [<a href="/pubmed/27781029" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27781029</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.mcrae.2017.433">McRae JF, Clayton S, Fitzgerald TW, Kaplanis J, Prigmore E, Rajan D, Sifrim A, Aitken S, Akawi N, Alvi M, Ambridge K, Barrett DM, Bayzetinova T, Jones P, Jones WD, King D, Krishnappa N, Mason LE, Singh T, et al.  Prevalence and architecture of de novo mutations in developmental disorders. <span><span class="ref-journal">Nature. </span>2017;<span class="ref-vol">542</span>:433–8.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.miceli.2015a.3782">Miceli F, Soldovieri MV, Ambrosino P, De Maria M, Migliore M, Migliore R, Taglialatela M. Early-onset epileptic encephalopathy caused by gain-of-function mutations in the voltage sensor of Kv7.2 and Kv7.3 potassium channel subunits. <span><span class="ref-journal">J Neurosci. </span>2015a;<span class="ref-vol">35</span>:3782–93.</span> [<a href="/pmc/articles/PMC6605567/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6605567</span></a>] [<a href="/pubmed/25740509" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25740509</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.miceli.2009.501">Miceli F, Soldovieri MV, Lugli L, Bellini G, Ambrosino P, Migliore M, del Giudice EM, Ferrari F, Pascotto A, Taglialatela M. Neutralization of a unique, negatively-charged residue in the voltage sensor of K V 7.2 subunits in a sporadic case of benign familial neonatal seizures. <span><span class="ref-journal">Neurobiol Dis. </span>2009;<span class="ref-vol">34</span>:501–10.</span> [<a href="/pubmed/19344764" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19344764</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.miceli.2015b.e15">Miceli F, Striano P, Soldovieri MV, Fontana A, Nardello R, Robbiano A, Bellini G, Elia M, Zara F, Taglialatela M, Mangano S. A novel KCNQ3 mutation in familial epilepsy with focal seizures and intellectual disability. <span><span class="ref-journal">Epilepsia. </span>2015b;<span class="ref-vol">56</span>:e15–20.</span> [<a href="/pubmed/25524373" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25524373</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.milh.2015.2314">Milh M, Lacoste C, Cacciagli P, Abidi A, Sutera-Sardo J, Tzelepis I, Colin E, Badens C, Afenjar A, Coeslier AD, Dailland T, Lesca G, Philip N, Villard L. Variable clinical expression in patients with mosaicism for KCNQ2 mutations. <span><span class="ref-journal">Am J Med Genet A. </span>2015;<span class="ref-vol">167A</span>:2314–8.</span> [<a href="/pubmed/25959266" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25959266</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.millichap.2016.e96">Millichap JJ, Park KL, Tsuchida T, Ben-Zeev B, Carmant L, Flamini R, Joshi N, Levisohn PM, Marsh E, Nangia S, Narayanan V, Ortiz-Gonzalez XR, Patterson MC, Pearl PL, Porter B, Ramsey K, McGinnis EL, Taglialatela M, Tracy M, Tran B, Venkatesan C, Weckhuysen S, Cooper EC. KCNQ2 encephalopathy: Features, mutational hot spots, and ezogabine treatment of 11 patients. <span><span class="ref-journal">Neurol Genet. </span>2016;<span class="ref-vol">2</span>:e96.</span> [<a href="/pmc/articles/PMC4995058/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4995058</span></a>] [<a href="/pubmed/27602407" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27602407</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.neubauer.2008.177">Neubauer BA, Waldegger S, Heinzinger J, Hahn A, Kurlemann G, Fiedler B, Eberhard F, Muhle H, Stephani U, Garkisch S, Eeg-Olofsson O, M&#x000fc;ller U, Sander T. KCNQ2 and KCNQ3 mutations contribute to different idiopathic epilepsy syndromes. <span><span class="ref-journal">Neurology. </span>2008;<span class="ref-vol">71</span>:177–83.</span> [<a href="/pubmed/18625963" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18625963</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.olson.2017.419">Olson HE, Kelly M, LaCoursiere CM, Pinsky R, Tambunan D, Shain C, Ramgopal S, Takeoka M, Libenson MH, Julich K, Loddenkemper T, Marsh ED, Segal D, Koh S, Salman MS, Paciorkowski AR, Yang E, Bergin AM, Sheidley BR, Poduri A. Genetics and genotype-phenotype correlations in early onset epileptic encephalopathy with burst suppression. <span><span class="ref-journal">Ann Neurol. </span>2017;<span class="ref-vol">81</span>:419–29.</span> [<a href="/pmc/articles/PMC5366084/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5366084</span></a>] [<a href="/pubmed/28133863" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28133863</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.painter.1981.1107">Painter MJ, Pippenger C, Wasterlain C, Barmada M, Pitlick W, Carter G, Abern S. Phenobarbital and phenytoin in neonatal seizures: metabolism and tissue distribution. <span><span class="ref-journal">Neurology. </span>1981;<span class="ref-vol">31</span>:1107–12.</span> [<a href="/pubmed/7196530" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7196530</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.porter.2012.103">Porter RJ, Burdette DE, Gil-Nagel A, Hall ST, White R, Shaikh S, DeRossett SE. Retigabine as adjunctive therapy in adults with partial-onset seizures: integrated analysis of three pivotal controlled trials. <span><span class="ref-journal">Epilepsy Res. </span>2012;<span class="ref-vol">101</span>:103–12.</span> [<a href="/pubmed/22512894" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22512894</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.rauch.2012.1674">Rauch A, Wieczorek D, Graf E, Wieland T, Endele S, Schwarzmayr T, Albrecht B, Bartholdi D, Beygo J, Di Donato N, Dufke A, Cremer K, Hempel M, Horn D, Hoyer J, Joset P, R&#x000f6;pke A, Moog U, Riess A, Thiel CT, Tzschach A, Wiesener A, Wohlleber E, Zweier C, Ekici AB, Zink AM, Rump A, Meisinger C, Grallert H, Sticht H, Schenck A, Engels H, Rappold G, Schr&#x000f6;ck E, Wieacker P, Riess O, Meitinger T, Reis A, Strom TM. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. <span><span class="ref-journal">Lancet. </span>2012;<span class="ref-vol">380</span>:1674–82.</span> [<a href="/pubmed/23020937" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23020937</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.rett.1964.609">Rett A, Teubel R. Neugeborenen Krampfe im Rahmen einer epileptisch belasten Familie. <span><span class="ref-journal">Wiener Klinische Wochenschrift. </span>1964;<span class="ref-vol">76</span>:609–13.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.ronen.1993.1355">Ronen GM, Rosales TO, Connolly M, Anderson VE, Leppert M. Seizure characteristics in chromosome 20 benign familial neonatal convulsions. <span><span class="ref-journal">Neurology. </span>1993;<span class="ref-vol">43</span>:1355–60.</span> [<a href="/pubmed/8327138" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8327138</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.sands.2016.2019">Sands TT, Balestri M, Bellini G, Mulkey SB, Danhaive O, Bakken EH, Taglialatela M, Oldham MS, Vigevano F, Holmes GL, Cilio MR. Rapid and safe response to low-dose carbamazepine in neonatal epilepsy. <span><span class="ref-journal">Epilepsia. </span>2016;<span class="ref-vol">57</span>:2019–30.</span> [<a href="/pubmed/27888506" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27888506</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.singh.2003.2726">Singh NA, Westenskow P, Charlier C, Pappas C, Leslie J, Dillon J, Anderson VE, Sanguinetti MC, Leppert MF., BFNC Physician Consortium.  KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum. <span><span class="ref-journal">Brain. </span>2003;<span class="ref-vol">126</span>:2726–37.</span> [<a href="/pubmed/14534157" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14534157</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.soldovieri.2014.356">Soldovieri MV, Boutry-Kryza N, Milh M, Doummar D, Heron B, Bourel E, Ambrosino P, Miceli F, De Maria M, Dorison N, Auvin S, Echenne B, Oertel J, Riquet A, Lambert L, Gerard M, Roubergue A, Calender A, Mignot C, Taglialatela M, Lesca G. Novel KCNQ2 and KCNQ3 mutations in a large cohort of families with benign neonatal epilepsy: first evidence for an altered channel regulation by syntaxin-1A. <span><span class="ref-journal">Hum Mutat. </span>2014;<span class="ref-vol">35</span>:356–67.</span> [<a href="/pubmed/24375629" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24375629</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.soldovieri.2011.365">Soldovieri MV, Miceli F, Taglialatela M. Driving with no brakes: molecular pathophysiology of Kv7 potassium channels. <span><span class="ref-journal">Physiology (Bethesda). </span>2011;<span class="ref-vol">26</span>:365–76.</span> [<a href="/pubmed/22013194" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22013194</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.striano.2006.218">Striano P, Bordo L, Lispi ML, Specchio N, Minetti C, Vigevano F, Zara F. A novel SCN2A mutation in family with benign familial infantile seizures. <span><span class="ref-journal">Epilepsia. </span>2006;<span class="ref-vol">47</span>:218–20.</span> [<a href="/pubmed/16417554" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16417554</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.sugiura.2009.82">Sugiura Y, Nakatsu F, Hiroyasu K, Ishii A, Hirose S, Okada M, Jibiki I, Ohno H, Kaneko S, Ugawa Y. Lack of potassium current in W309R mutant KCNQ3 channel causing benign familial neonatal convulsions (BFNC). <span><span class="ref-journal">Epilepsy Res. </span>2009;<span class="ref-vol">84</span>:82–5.</span> [<a href="/pubmed/19167866" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19167866</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.tulloch.2012.31">Tulloch JK, Carr RR, Ensom MH. A systematic review of the pharmacokinetics of antiepileptic drugs in neonates with refractory seizures. <span><span class="ref-journal">J Pediatr Pharmacol Ther. </span>2012;<span class="ref-vol">17</span>:31–44.</span> [<a href="/pmc/articles/PMC3428186/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3428186</span></a>] [<a href="/pubmed/23118657" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23118657</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.uehara.2008.55">Uehara A, Nakamura Y, Shioya T, Hirose S, Yasukochi M, Uehara K. Altered KCNQ3 potassium channel function caused by the W309R pore-helix mutation found in human epilepsy. <span><span class="ref-journal">J Membr Biol. </span>2008;<span class="ref-vol">222</span>:55–63.</span> [<a href="/pubmed/18425618" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18425618</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.wang.1998.1890">Wang HS, Pan Z, Shi W, Brown BS, Wymore RS, Cohen IS, Dixon JE, McKinnon D. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. <span><span class="ref-journal">Science. </span>1998;<span class="ref-vol">282</span>:1890–3.</span> [<a href="/pubmed/9836639" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9836639</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.wang.1996.17">Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, Shen J, Timothy KW, Vincent GM, de Jager T, Schwartz PJ, Toubin JA, Moss AJ, Atkinson DL, Landes GM, Connors TD, Keating MT. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. <span><span class="ref-journal">Nat Genet. </span>1996;<span class="ref-vol">12</span>:17–23.</span> [<a href="/pubmed/8528244" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8528244</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.weckhuysen.2012.15">Weckhuysen S, Mandelstam S, Suls A, Audenaert D, Deconinck T, Claes LR, Deprez L, Smets K, Hristova D, Yordanova I, Jordanova A, Ceulemans B, Jansen A, Hasaerts D, Roelens F, Lagae L, Yendle S, Stanley T, Heron SE, Mulley JC, Berkovic SF, Scheffer IE, de Jonghe P. KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy. <span><span class="ref-journal">Ann Neurol. </span>2012;<span class="ref-vol">71</span>:15–25.</span> [<a href="/pubmed/22275249" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22275249</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kcnq3-dis.REF.zara.2013.425">Zara F, Specchio N, Striano P, Robbiano A, Gennaro E, Paravidino R, Vanni N, Beccaria F, Capovilla G, Bianchi A, Caffi L, Cardilli V, Darra F, Bernardina BD, Fusco L, Gaggero R, Giordano L, Guerrini R, Incorpora G, Mastrangelo M, Spaccini L, Laverda AM, Vecchi M, Vanadia F, Veggiotti P, Viri M, Occhi G, Budetta M, Taglialatela M, Coviello DA, Vigevano F, Minetti C. Genetic testing in benign familial epilepsies of the first year of life: clinical and diagnostic significance. <span><span class="ref-journal">Epilepsia. </span>2013;<span class="ref-vol">54</span>:425–36.</span> [<a href="/pubmed/23360469" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23360469</span></a>]</div></li></ul></div></div><div id="kcnq3-dis.Chapter_Notes"><h2 id="_kcnq3-dis_Chapter_Notes_">Chapter Notes</h2><div id="kcnq3-dis.Acknowledgments"><h3>Acknowledgments</h3><p>The Authors acknowledge funding agencies for supporting their studies; in particular: Telethon GP15113, Italian Ministry for Education and Research (SIR RBSI1444EM), Citizens United for Research in Epilepsy, The Jack Pribaz Foundation, KCNQ2 Cure Alliance, and NINDS (NS49119). Collaborations from patients and their families are also highly appreciated.</p></div><div id="kcnq3-dis.Author_History"><h3>Author History</h3><p>Giulia Bellini, PhD; Second University of Naples (2014-2017)<br />Edward C Cooper, MD, PhD (2017-present)<br />Giangennaro Coppola, MD; University of Salerno (2014-2017)<br />Nishtha Joshi, BDS, MPH (2017-present)<br />Francesco Miceli, PhD (2014-present)<br />Emanuele Miraglia del Giudice, MD; Second University of Naples (2014-2017)<br />Maria Virginia Soldovieri, PhD (2014-present)<br />Maurizio Taglialatela, MD, PhD (2014-present)<br />Sarah Weckhuysen, MD, PhD (2017-present)</p></div><div id="kcnq3-dis.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>7 September 2017 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>22 May 2014 (me) Review posted live</div></li><li class="half_rhythm"><div>26 September 2013 (mt) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK201978</span><span class="label">PMID: <a href="/pubmed/24851285" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">24851285</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/bfns/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/kcnt1-epilepsy/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK201978&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK201978/?report=reader">PubReader</a></li><li><a href="/books/NBK201978/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK201978" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK201978" style="display:none" title="Cite this Page"><div class="bk_tt">Miceli F, Soldovieri MV, Joshi N, et al. KCNQ3-Related Disorders. 2014 May 22 [Updated 2017 Sep 7]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK201978/pdf/Bookshelf_NBK201978.pdf">PDF version of this page</a> (531K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#kcnq3-dis.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#kcnq3-dis.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#kcnq3-dis.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#kcnq3-dis.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#kcnq3-dis.Genetically_Related_Allelic_Di" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#kcnq3-dis.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#kcnq3-dis.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#kcnq3-dis.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#kcnq3-dis.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#kcnq3-dis.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#kcnq3-dis.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#kcnq3-dis.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3786[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KCNQ3</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=3097608" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=3097608" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=3097608" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=3097608" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20437616" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">KCNQ2</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">KCNQ2</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Miceli F, Soldovieri MV, Joshi N, Weckhuysen S, Cooper E, Taglialatela M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29334453" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PRRT2</i>-Associated Paroxysmal Movement Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PRRT2</i>-Associated Paroxysmal Movement Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ebrahimi-Fakhari D, Moufawad El Achkar C, Klein C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301494" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SCN1A</i> Seizure Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SCN1A</i> Seizure Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Miller IO, Sotero de Menezes MA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30234941" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">KCNT1</i>-Related Epilepsy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">KCNT1</i>-Related Epilepsy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gertler T, Bearden D, Bhattacharjee A, Carvill G. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30782577" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A novel mutation in KCNQ3-related benign familial neonatal epilepsy: electroclinical features and neurodevelopmental outcome.</a><span class="source">[Epileptic Disord. 2019]</span><div class="brieflinkpop offscreen_noflow">A novel mutation in KCNQ3-related benign familial neonatal epilepsy: electroclinical features and neurodevelopmental outcome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Piro E, Nardello R, Gennaro E, Fontana A, Taglialatela M, Donato Mangano G, Corsello G, Mangano S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Epileptic Disord. 2019 Feb 1; 21(1):87-91. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=24851285" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=24851285" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0412a5dd21425a25b7d534">KCNQ3-Related Disorders - GeneReviews®</a><div class="ralinkpop offscreen_noflow">KCNQ3-Related Disorders - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:53:41-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE88FE4DE040EED100000000019D0084&amp;ncbi_session=CE88FE4DE0412A41_0413SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK201978%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK201978&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK201978/&amp;ncbi_pagename=KCNQ3-Related Disorders - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE88FE4DE0412A41_0413SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>